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1. VASCULAR SYSTEM 
 
Vascular system is a close, double and complete system that carry the 
blood in every human body  district; it contain the heart, the central organ 
and propeller of blood circulation, and blood vessels, divided into artery, 
vein, capillary in which the blood flow. Vascular system begins with the 
aorta, the main and largest artery, that through several forks give origin to 
minor arteries with a decreasing diameter (from 25 mm in aorta to 0,2 mm 
in arterioles) that reach organs and tissues. Depending on the caliber and on 
the quantity in the thickness of the vessel wall of elastic fibers and muscle 
fibrous cells we can distingue elastic and muscular arteries and arterioles 
and they are a transporter of oxygenated blood from the heart to all the 
peripheral tissues of the organism. Arterioles ramify in lower caliber 
arterial vessels becoming thinner near organs and forming nets know as 
capillary plexus that is regarded as a bridge between arteries and veins, 
which are involved in the exchange of substances between blood and 
tissues. Thanks to their small diameter (5-10 µm), their thin wall with a 
single layer of endothelial cells and the low hydrostatic pressure with 
which blood flow into, capillaries can easily exchange breathing gases, 
nutrients, enzymes, hormones and waste products. After the release of the 
necessary substances and building-up of deoxygenated blood rich of carbon 
dioxide the blood pass from the capillaries to very small veins (venules) 
that carry this blood from periphery to the heart. Those small veins merge 
each other forming a decreasing number of veins with an increasing caliber 
till they flow in the cave vein that reaches the heart. Vein‟s characteristics 
are the quite thin wall, they are not really elastic comparing to same caliber 
artery even if they have a similar structural organization. Major caliber 
veins contain special valves, known as swallow nest that impede the blood 
ebb, contributing to the regulation of blood flow in a centripetal way. 
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Arteries and veins are classified mainly by their anatomic position and 
divided in 3 main classes: Resistance vessels (arteries and arterioles); 
Exchange vessels (capillaries, sinusoid and venules) and at the end capacity 
vessels (veins) (Stranding S 2009). 
 
 
1.1  BLOOD VESSELS: HISTOLOGY and CLASSFICATION 
 
All arterial system wall is constituted by 3 concentric laminas: Internal 
laminae (intimal), Medial Laminae (mesoartery) and External Laminae 
(adventitia). Between those laminae, as bounds, there are 2 other laminae 
of elastic tissue, called inner elastic and outer laminae. (Fig.1) 
 
 
 
 
 
 
Fig.1: The three concentric laminas of artery wall: intima, media, and adventitial 
layer. a) Schematic representation; b) Histology (H&E)  
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Intimal Tunica 
The Intimal tunica is the most internal layer, in close contact with the 
flowing blood; it is constituted by an endothelial and a sub-endothelial 
layer. The endothelial layer presents a single line of endothelial cells that 
are overlooking to the longitudinal axis of the vessel. Those cells are 
present in the whole vascular system and in the heart. The endothelial cell 
leans on a meagre layer of loose connective tissue, or sub-endothelial 
laminae, with mesenchymal cell interpose in it, fibroblast end rare smooth 
muscle cells. The intimal tunica acts as an interface with the blood and 
guarantee the regolation of the transport of material and blood through 
tissues. 
 
Medial Tunica 
The medial Tunica is the intermedial layer between the intimal and 
adventitia, separated by the internal and external elastic laminae. In the 
large is the thickest tunica, that mainly presents the vessel, and permit a 
taxonomic placement. Medial tunica contains in essence smooth muscle 
cells in a matrix rich in elastic fibers, collagen and proteoglican; those 
components are always present in the vessel wall, the amount of each 
component is different according to the area in which they are. Medial 
tunica smooth muscle cells are roundly arranged in the vessel lumen. 
The activation of the sympathetic permit both the twitch of the vessel, 
reducing his diameter, (vasoconstriction) and the relax of the vessel, 
increasing his diameter, (vasodilatation); those actions leads to changing in 
both blood pressure and bloodstream through the vessel. Medial tunica 
separate from the adventitial tunica by an aggregate of elastic fibers called 
external elastic laminae. The role of the medial tunica is both to bestow 
elasticity to the vessel (in big caliber arteries there are abundant elastic 
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fibers and few contractive ones) and contraction (in muscular arteries there 
are more muscular than elastic components). 
 
Adventitial Tunica 
The adventitial tunica is placed externally to the external elastic laminae, it 
is a loose connective tissue, rich in collagen fibers sprawling orientated, 
few smooth muscle and inflammatory cells, and adipocytes. It can be 
considered a connective sheath, with a containing role; it glides into the 
surrounding connective tissue securing steadily blood vessels. In large and 
medium caliber vessels the adventitial tunica can be well-developed to hold 
in his thickness both vasa vasorum (small vessels drizzling and feeding 
vascular wall) and nerva nervorum (vegetative sympathetic fibers 
controlling mainly the smooth muscle fibers of the medial tunica). 
 
From the heart to peripheral capillaries blood flow through a network of 
arteries with a decreasing diameter; by their size and structural 
characteristics arteries are distinguished in large caliber elastic artery, 
medium caliber muscular artery and small caliber artery different by 
contractility and elasticity. Different composition gives also different 
characteristic in the conduction and distribution suitable with the anatomic 
area in which they are. Both kind of artery present the same wall structure 
with the 3 layers, the difference between elastic and muscular arteries 
depend on the amount of elastic tissue in the medial tunica (Fig.2). 
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Fig.2: Differences between elastic and muscular arteries. a) Schematic 
representation; b) Modulation of elastic and muscular components depending on 
the parietal thickness 
 
 
Large arteries or elastic arteries or conduction arteries: large vessels that 
carry the blood from the heart to the muscular arteries. Examples of elastic 
arteries are pulmonary trunks and aortic arch and their principal branches 
(such as pulmonary artery, common carotyd, subclavian and iliac 
common).The vessel wall, characterized by numerous elastic fibers, is thin 
and presents an ample lumen with a diameter over 2,5 cm. Medial tunica is 
rich of elastic fibers (40-70 concentric elastic laminae) extremely 
extending, able to accumulate energy impressed on the haematic mass by 
ventricular systols and release it slowly during diastole to the blood flowing 
toward the periphery. The aim is convert the intermittent haematic flow 
deriving from the heart into a continuous (laminar) flow, necessary to the 
peripheral district (capillary) in which there will be the exchanges. 
 
Medium caliber arteries or muscular arteries or distribution arteries: 
receive blood from elastic arteries, from which originate, and release it to 
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skeletal muscles and internal organs too. Classic examples of muscular 
arteries are external carotid artery, bronchial arteries, femoral arteries and 
mesentheric arteries. Those arteries present variable diameters, from 2,5 to 
7 mm, with a large lumen and a strong not elastic wall, that modify itself to 
become mainly a leiomuscular component, in fact they must be able to help 
with its contractions the blood to flow where heart force is not sufficient to 
let the blood going on. Medial tunica presents 40-70 layers of concentric 
smooth muscle cells that, wrapping in a concentric way as opposed to the 
vessel axis, form a kind of muff around it. There are no elastic lamellae, 
with the exception of the elastic layers, the internal and the external one. 
 
Small caliber arteries or arterioles: are artery branches that arrive to the 
capillary, its diameter is less than 0,5mm. Rich in muscular tissue, those 
small arteries are characterized by a gradual loss of elastic tissue, elastic 
internal and external laminae appear as fragmented, and it is difficult to 
discern all layers. They present also a small lumen and a thick and 
contractile vessel wall that regulates and control flow resistance (Martini 
2003). 
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2. STEM CELLS 
 
Stem cell research is one of the most fascinating areas of contemporary 
biology since the cells are "parent" of each organ, tissue and organism cell 
type, due to their, innate properties to renew themselves for an indefinite 
period, known as “immortal” because they are able to develop into 
specialized cells of various body tissues in early life and growth. These 
specific characteristics make cells stem very promising for the treatment of 
severely debilitating degenerative diseases and could be interesting for 
many applications in tissue engineering, cells therapy and drug screening. 
The biology of stem cells is important in understanding the ontogeny but 
also to maintain homeostasis by replacing damage cells in adult organism. 
 
 
2.1 DEFINITION and CLASSIFICATION 
 
 Stem cells differ from other cells type in the body and depending on their 
origin; they can be distinguished in three important characteristics (Fig.3) 
(National Institute of Health 2002; Ulloa-Montoya et al., 2005): 
 
Stem cells are capable to self-dividing and self-renew: they are able to 
renew themselves through numerous cycles of cell division for long periods 
maintaining the undifferentiated state. During early development, stem cell 
division is symmetrical i.e. each cell divides itself to give rise to two 
unspecialized daughter cells, like the parent, each one with the same 
potential. In the later development, the cell divides itself asymmetrically 
with of the daughter cells will maintain a stem characteristic and the second 
will be a more differentiated cell.  
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Stem cells are unspecialized: they haven‟t acquired yet any tissue-specific 
structures that allow them to perform specialized functions like the ability 
to become any cell type.  
 
Stem cells are able to give rise to specialized cells: under special 
conditions, unspecialized cells begin to "differentiate" into specialized cell 
type and to develop into specific tissues and organs. Each step of the 
differentiation is trigger by internal signals (cell‟s genes) and external 
signals such as cytokines and chemokines secreted by other cells, physical 
contact with adjacent cells and other molecules in the microenvironment.  
 
 
 
 
 
 
 
 
Fig.3: Definition of “stem cells” 
 
Depending on differentiation potential, stem cells are classified in: 
totipotent, pluripotent, multipotent and unipotent. All human beings start 
their lives from a single cell called a “zygote”, produced from the fusion of 
an egg and a sperm cell. The zygote is defined the totipotent stem cell and 
can differentiate into embryonic and extra-embryonic cell types 
constructing a complete, viable, organism. The zygote, after a series of 
multiple successive divisions, in about 5 days, gives rise to cave spherical 
agglomerate known as blastocyst.  Embryonic Stem Cells, originate as 
inner mass cells within a blastocyst, are capable to differentiate into cells 
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from all three germinal layers: endoderm, mesoderm and ectoderm and to 
generate all tissues present into adult organism thank to their characteristic 
pluripotency. The Adult Stem Cells or Somatic Stem Cells, typically 
programmed to give rise to different cell types of the tissue of derivating, 
are called multipotent cell and can give rise only to certain cell types. The 
main role of adult stem cells in a living organism is to maintain and to 
repair the tissue in which they are found. The unipotent stem cells have the 
capacity to differentiate into only one type of cell or tissue, which is a 
lower potential. Despite their limited differentiation potential, unipotent 
cells still have therapeutic potential to treat injuries and diseases. We can 
assert that a stem cell with its characteristic open a new research  for its 
possible therapeutic for degenerative diseases like Alzheimer disease, 
Parkinson disease, stroke, cardiopathy, diabete and cancer (Fig.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4: Classification and destiny of “stem cells” 
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2.2 EMBRYONIC STEM CELLS 
 
Embryonic Stem Cells (ESCs) derived from totipotent cells of the early 
mammalian embryo and are capable of unlimited and undifferentiated 
proliferation in vitro. These stem cells obtained from the epiblast tissue of 
the inner cell mass (ICM) of a blastocysts, of a 4-5 days old embryos, 
consisting of 50-150 cells (Fox news) (Fig.5).  
 
 
 
 
 
 
 
 
 
 
 
Fig.5: Schematic representation to obtain ESCs 
 
ESCs are the best characterized of all the stem cells; they are pluripotent 
thank of the ability to differentiate into cells deriving from the three main 
germ lines: ectoderm (neurons, skin, etc), mesoderm (muscle and bone) and 
endoderm (Hepatocytes, pancreatic beta cells) and not contributing to the 
extra-embryonic membranes (Fig.6). We can assert that sufficiently and 
necessarily stimulate for a specific cell type, they can develop into almost 
all cell types of the adult body. ESCs are immortal, have been maintained 
in culture for several doublings, and are able to maintain a normal 
karyotype (Amit et al., 2003).  
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Fig.6: Pluripotency of ESCs 
 
The mouse embryos ESCs have been isolated and cultured since the 1980 
by various groups of researchers (Evans et al., 1981, Axelrod 1984, Wobus 
et al, 1984, Doetschman et al., 1985). These pioneers established that 
murine embryonic stem cells line could differentiate into several different 
cell types (Thompson et al., 1995, 1998) and when injected into a pre-
implantation embryo, can produce functional differentiated progeny in all 
tissue and organ (Smith et al., 2001). 
In 1995 and 1998, ESCs were isolated from primate and human (Amit et 
al., 2003). human Embryonic Stem Cells (hESCs) should be able to give 
the same results of mouse Embryonic Stem Cells (mESCs), but for ethical 
reasons it cannot be demonstrated. ESCs, as their name suggests, derive 
from embryos produced with in vitro fertilization (IVF) for clinical purpose 
and then donated for research purposes with informed consent of the 
donors. ESCs were defined by the presence of several transcription factors 
and cell surface protein further by cellular morphology. The transcription 
factors Oct-4 (Octamer-4), Nanog and Sox2 (Sex determining region Y-
box2) form the core regulatory network that ensures the suppression of 
gene that lead to differentiation and the maintance of pluripotency (Boyer 
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et al., 2005). The cell surface antigens commonly used to identify mESCs 
are Stage-Specific Embryonic Antigen-1 (SSEA-1), the glycolipids SSEA3, 
SSEA4 (Henderson et al., 2002) and the keratan sulfate antigens Tra-1-60 
and Tra-1-81. The undifferentiated state of hESCs was maintained in 
culture condition, they grown on a feeder layer of mouse embryonic 
fibroblasts (MEFs) and require the presence of basic Fibroblast Growth 
Factor (bFGF or FGF-2)(National Institutes of Health). The differentiation 
potential was tested in vitro by suspension culturing that form three-
dimensional mature cells aggregate derived by ectodermal, endodermal e 
mesodermal line called embryoid bodies (EBs)(Shamblott et al., 1998); 
their following injection into immunodeficient mice, develop teratomas that 
typically contain a mixture of many, differentiated or partly differentiated, 
cell types of the  ectoderm, mesoderm and endoderm layers (Wobus et al., 
1984; Reubinoff et al., 2000) this could be a disadvantage for cell therapy. 
ESCs remain a potentially source for regenerative medicine and tissue 
replacement after injury or disease; but considering the ethical issue, the 
possible development of teratomas and highly immunogenic potential has 
prompted researchers to study the Adult Stem Cells or Somatic Stem Cells.  
 
 
2.3 ADULT STEM CELLS or SOMATIC STEM CELLS 
 
The term Adult Stem Cells (ASCs), also known as Somatic Stem Cells 
(SSCs), refers to any stem cell which is found in a developed organism, in 
children as well as adults. ASCs seems to be an undifferentiated cell that 
can renew itself and differentiate in almost the total of the major 
specialized cell types related to the tissue or organ (Gardner, 2002); some 
of them are indeed lineage-restricted (multipotent) and are generally 
referred to their tissutal origin (i.e. adipose-derived stem cell, 
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etc).(Barrilleaux et al., 2006, Gimble et al., 2007). The primary roles of 
ASCs in a living organism are to maintain and to repair the tissue in which 
they reside; they are also presents in several different tissues including 
bone marrow, blood, brain, peripheral blood, blood vessels, skin, teeth, 
heart, liver, skeletal muscle, testis and ovarian epithelium and those 
findings led us to believe that ASCs can be used for transplantation-based 
therapies. In fact, the use of ASCs in research and therapy is not as 
controversial as ESCs, because the production of these cells does not 
require the destruction of an embryo.  
ASCs research of began in 1960, when some researchers discovered that 
the bone marrow contains two population of stem cells: HEMATOPOIETIC 
STEM CELLS (HSCs) forming all types of blood cells in the body (Islam, 
1985) and MESENCHYMAL STEM CELLS (MSCs) discovered 
subsequently and they can generate bone, cartilage, fat and cell that support 
the formation of blood and fibrous connective tissue. (Friedenstein et al., 
1974) (Fig.7) 
 
Fig.7: Adult Stem Cells in the bone marrow 
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The HSCs are the best characterized multipotent stem cells that give rise to 
all the blood cell types including myeloid and lymphoid lineages and 
contain cells with long-term and short-term regeneration capacities and 
committed multipotent, oligopotent, and unipotent progenitors. The HSCs 
were isolated from bone marrow in the mouse (Spangrude et al., 1988) and 
in murine transplantation experiments it has been demonstrated that one 
single HSCs reconstitute the entire mouse blood tissue (Smith et al., 1991). 
Subsequently, HSCs were found and isolated also in adult human tissues 
like bone marrow, umbilical cord blood, placenta and peripheral blood by 
the expression of cell surface marker CD34
+
/CD38
-
. The role of HSCs is to 
differentiate continuously into multiple lineage of different blood cell type 
and replicate themselves thanks to their self-renewal ability to prevent the 
depletion of the stem cells pool in bone marrow (Huang et al., 2007). 
HSCs have been studied by scientists for many years, and they were the 
first stem cells from the bone marrow to be used successfully in therapies. 
In fact BM-HSCs have been used for decades to treat blood cancer ( i.e. 
leukemia) and other blood disorders such as aplastic anemia, thalassemia, 
etc (Ulloa-Montoya et al., 2005) and more recently, to treat breast cancer 
and coronary artery disease. The HSCs are mostly quiescent cells and are 
about the ≈ 0.05% of the bone marrow components and through intrinsic 
and extrinsic signals, they proliferate and differentiate into progenitor cells 
which eventually give arise to terminally differentiate cells in the 
peripheral blood. External environmental signals must integrate with 
intrinsic molecular mechanisms to control HSCs fate. In particular, several 
transcription factors are implicated in the regulation of self renewal such as 
transcription factor translocation Ets leukemia (tel )(Hock et al., 2004), 
Hox4 (Sauvageau et al., 2004), signal transducer and activator of 
transcription 5 (Stat5) (Kato et al., 2005), Stat3 (Chung et al., 2006). In 
addition, it was demonstrated that several proteins involved in the 
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modulation of gene expression are necessary to regulate HSCs self-renewal 
such as B lymphoma Mo-MLV insertion region 1 (BMI-1),which together 
leading to the repression of transcriptional activity through the maintaining 
of epigenetic memory (Iwama et al., 2004). On the other hand, the 
environment signals implicated in the regulation of HSCs and self-renewal 
are the transduction pathways of Notch (plays an important role in cell fate 
for maintaining HSCs in the undifferentiated state (Varnum-Finney et al., 
2000, Calvi et al., 2003), WNT (Duncan  et al., 2005) and bone 
morphogenetic protein (BMP).  
A number of other adult stem cells have been studied even if they weren‟t 
as well characterized as HSC. Neural Stem Cells (NSCs) that give arise to 
neurons, astrocytes and oligodendrocytes (Gage 2000). Mesenchymal Stem 
Cells (MSCs) that differentiate into fibroblasts, osteoblasts, chondrablasts, 
adipocytes and skeletal muscle. (Pittenger et al., 1999, Prockop 1997, 
Friedestein 1982). Other stem cells have been identified, including 
gastrointestinal stem cells (Potten 1998), epidermal stem cells (Watt 1998) 
and hepatic stem cells(also called oval cells)(Alison et al., 1998).  The idea 
that stem cell are committed cells has been recently challenged by several 
bizarre and unexpected findings. Several experiments have suggested that 
certain adult stem cells types are pluripotent and can transdifferentiate into 
different cell types not only of the origin tissue but also other tissue i.e. 
hematopoietic stem cells may differentiate into three major types of brain 
cells (neurons, oligodendrocytes and astrocytes) (Krause et al., 2001); bone 
marrow stromal stem cells into cardiac muscle cells (Ferrari et al.,1998) 
and endothelium (Rafii et al., 1994; Asahara et al., 1997), and brain stem 
cells into blood cells (Bjornson et al., 1999)  and dental pulp stem cells into 
neural tissue (Shen et al., 2003). This reported phenomenon is called 
plasticity (Fig.8). 
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Fig 8: Plasticity of Adult Stem Cells 
 
It has also recently demonstrated that certain adult cell types can be 
“reprogrammed” into other cell types using an in vivo well-controlled 
genetic modification process. For example, pancreatic beta cells, the 
insulin-producing cells that are lost or damaged in diabetes, could possibly 
be created by other reprogramming pancreatic cells (Zhou et al., 2008). In 
addition, beside the reprogram of the cell to become a specific cell type, it 
is now possible to reprogram adult somatic cells, through the introduction 
of embryonic genes, to become like embryonic stem cells a process called 
induced pluripotent stem cells (iPSCs). 
Adult stem cells offer a hope in the future for cell therapy to treat diseases 
like Parkinson, Alzheimer, stroke, heart disease, diabetes and rheumatoid 
arthritis. In addition, using patient's own cells it can be overcome the 
immunological compatibility issue. But ASCs are rare in mature tissue and 
it‟s still a challenge and expanding methods in culture, have not yet been 
worked out. This is an important problem because for stem cell 
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replacement therapies it‟s necessary a large numbers of cells. However, 
ESCs have been found to be better for both differentiation potential and 
ability to divide themselves in culture, but their production meets strong 
resistance and limitations of ethical issues.  
 
 
2.4 MESENCHYMAL STEM CELL 
 
The adult bone marrow contains not only the hematopoietic stem cells, but 
also MSCs that represent an archetype of multipotent adult stem cell 
capable of giving arise to a number differentiated mesodermal cells of 
various type, including chondrocytes, osteocytes, adipocytes, myocytes and 
bone marrow stromal cells (Deans et al., 2000, Pittenger et al., 1999); that 
can be promising for their application in regenerative medicine. Interest in 
MSCs began over 130 years ago when Cohnheim, a German pathologist, 
suggested that the bone marrow gave rise to fibroblast-like cells during the 
repair process (Ross et al., 1970, Petrakis et al., 1961). Later in 1976, 
Friedenstein described first the fibroblast precursor from bone marrows 
capable of osteogenesis. Since their original description, these bone 
marrow multipotent progenitors were known with different names. The 
original term “colony forming unit-fibroblast (CFU-F)” or “marrow 
stromal fibroblasts (MSF)” (Castro-Malaspina et al., 1980, Piersma et al., 
1985, Kuznetsov et al., 1997) has been gradually abandoned and replaced 
by different and still indistinct denominations like “marrow stromal cells 
(MSCs)” (Prockop et al., 1997), “mesenchymal stem cells (MSCs)” 
(Caplan et al., 1994), or mesenchymal progenitor cells (Conget et al., 
1999). An attempt to clarify the nomenclature for MSCs has recently been 
proposed by the International Society for Cellular Therapy and discussed at 
several international meetings such as Adult Mesenchymal Stem Cells in 
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Regenerative medicine (MSC 2007, http://www.msc2007.net). Although 
MSCs were originally isolated from bone marrows (Friedenstein et al., 
1966, Pittenger et al., 1999), similar populations reside in a different 
numbers of adult and fetal (in ’t Anker et al., 2003) tissues, including the 
spleen, amniotic fluid, cartilage, muscle, tendons, peripheral blood 
(Zvaifler et al., 2000, Kuznetsov et al., 2001) and tissue adipose (Zuk et al., 
2001, Alhadlaq et al., 2004)  and more recently from deciduous tooth, fetal 
membrane (Zhang et al., 2004) and umbilical cord (Bieback et al., 2004, 
Kogler et al., 2004). Initially, peripheral blood was the first sources studied 
for its easy availability. Only one research‟s group isolated mononuclear 
cells population by adherence, morphology, phenotype and differentiation 
potential typical characteristics of MSCs; these cells were isolated from 
over 100 samples of peripheral blood of healthy volunteers, but these data 
haven‟t never been confirmed  (Zvaifler et al., 2000). Alternative sources 
are the fetal membrane a fetal discarded tissue and above all they don‟t 
generate ethical conflicts. Moreover, MSCs have high efficient recovery 
with no intrusive procedures (Alviano et al., 2007); the umbilical cord 
blood is rich in MSCs, because during embryonic development the 
embryonic hematopoiesis change site, from the yolk sac, the initial site, to 
liver and then to bone marrow with a consequent migration of HSCs and 
MSCs; but an interesting source could be the adult dental pulp and adipose 
tissue, very accessible tissue research. Many studies showed the presence 
of stem cells in dental pulp (Gronthos et al., 2000, Pierdomenico et al., 
2005) and adipose tissue (De Ugarte et al., 2003, Zuk et al., 2002) 
possessing stem cell-like qualities, including a good self-renewal and 
multilineage differentiation (adipogenic and osteogenic) abilities. This 
source could still be a fascinating subject of study and a valuable 
therapeutic tool. 
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In bone marrow, MSCs are important components of the HSCs niche. In 
fact, all niche‟s components like stroma, stromal cells (endothelial cells, 
adipocytes, macrophages, reticular cells, fibroblasts and osteoprogenitors) 
and cellular microenvironment, where MSCs are presumed to exist, ensure 
the survival and growth of HSCs (Koller et al., 1997, Strobel et al., 1986, 
Tavassoli et al., 1982).  MSCs have been defined by their plastic adherent 
growth and subsequent expansion under specific culture conditions, by a 
panel of non-specific surface antigens and by their in vitro e in vivo 
differentiation potential (Javazon et al., 2004). The gold standard assay 
utilized to identify MSC is CFU-F assay which identifies adherent, spindle-
shaped cells that proliferate to form colonies (Friedenstein et al., 1970). 
MSCs, with their fibroblast-like morphology, were initially isolated as the 
plastic adherent fraction of bone marrow (Friedenstein et al., 1970). A 
Percoll density gradient was used to eliminate unwanted cell types, present 
in the bone marrow aspirate, and the present MSCs were a small percentage 
(estimated at about 0.001-0.01%). The general procedure used to isolate 
mononuclear cells is a gradient centrifugation and the following seeding on 
culture plates in medium with fetal bovine serum (FBS). After attachment 
of the adherent cell fraction, the medium is removed to eliminate non-
adherents cell, the adherents cell are so expanded in a limited number of 
passages (Ulloa-Montoya et al., 2005). Although there aren‟t specific 
markers MSCs, many attempts have been made to develop a cell-surface 
antigen profile to improve the purification and identification of MSCs. 
Minimal criteria, to define human MSCs proposed by the Mesenchymal 
and Tissue Stem Cell Committee of the International Society for Cellular 
Therapy (Dominici et al., 2006), are the positivity for the following 
antigens:  
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 CD105 this antibody SH2 identifies an epitope of endoglin (CD105), 
the Transforming growth factor beta (TGFβ) receptor III present on 
endothelial cells, erythroblasts, monocytes, and connective tissue 
stromal cells and facilitates enrichment of stromal progenitors from 
bone marrow (Short et al., 2003); 
 
 CD73 a glycoprotein, identified by monoclonal antibody SH3 and 
SH4, involved in B-cell activation (Short et al., 2003). It is expressed 
by lymphocytes and endothelial cells; 
 
 CD90 or Thy1: a 25–37 kDa heavily N-glycosylated, 
glycophosphatidylinositol (GPI) anchored conserved cell surface 
protein, originally discovered as a thymocyte antigen. Thy-1 can be 
used as a marker for a variety of stem cells and for the axonal 
processes of mature neurons. Structural study of Thy-1 lead to the 
foundation of the Immunoglobulin superfamily. 
 
In contrast, the MSCs were negative for other markers of the hematopoietic 
lineage including CD34(a transmembrane protein that defined ˜ 1% of 
normal bone marrow mononuclear cells including hematopoietic 
precursors/stem cells and normal endothelial cells and its is considered a 
primitive HSCs marker); CD31(glycoprotein also designed platelet 
endothelial cell adhesion molecule-1 (PECAM-1) that is normally 
expressed on endothelial cells, circulating and tissutal hematopoietic cells 
including platelets, monocytes/macrophages, granulocytes and B-cells); 
CD45( recognizes a family of proteins known as the leukocyte common 
antigen exclusively expressed on the surface of almost all haemato-
lymphoid cells and their progenitors) and CD14 or CD11b (an immune cell 
marker).  
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The identification of a definitive marker that allows the isolation of MSCs 
from fresh tissue could be very important. Stro-1 is the best-know MSC 
marker because the cell population negative for Stro-1 is not capable to 
form colonies. Stro-1 positive cells can become HSC-supporting 
fibroblasts, smooth muscle cells, adipocytes, osteoblasts and chondrocytes 
(Dennis et al., 2002) which reinforce the functional role of MSCs. In 
addition, the expression of Stro-1 distinguishes two cultured population of 
MSCs with different homing and HSC-supportive capacities (Bensidhoum 
et al., 2004). However, Stro-1 is not specific for these cells and its 
expression in MSCs is gradually lost during culture expansion (Gronthos et 
al., 2003), so the Stro-1 labeling to isolate and/or identificate MSCs it‟s 
possible only during early passages. In some cases, other cell surface 
markers have been empirically used to isolate the human bone marrow 
mononuclear cells by fluorescence-activated cell sorting (FACS) or 
magnetic bead cell sorting based both on the expression of several markers 
including, CD49b, CD146, CD130, CD200, CD44, CD166.  
Since that were first discovered, several studies demonstrated the 
multilineage differentiation potential of MSCs populations showing their 
capacity to develop into terminally differentiated mesenchymal phenotypes 
including bone (Bruder et al., 1997), cartilage (Kadiyala et al., 1997), 
tendon (Young et al., 1998), muscle (Ferrari et al., 1998), adipose tissue 
(Dennis et al., 1999) and hematopoietic-supporting stroma (Prockop et al., 
1997) (Fig.9) and showing also a high degree of plasticity (D’Ippolito et 
al., 2004, Zhao et al., 2002). 
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Fig.9: The mesengenic process of MSCs 
 
Furthermore, MSCs can commit to a particular differentiation pathway by 
their self-renewal and proliferation abilities and the micro-environmental in 
which they are. The lineage-committed cell progresses through several 
stages of maturation process a terminal differentiation, which is 
characterized by the cessation of proliferative capacity and the synthesis of 
tissue-specific markers, including components of the extracellular matrix 
(ECM)(Baksh et al., 2004). 
Individual colonies derived from single MSC precursor have also been 
reported to be heterogeneous for their multilineage differentiation potential 
(Friedenstein et al., 1970). In the 1999, Pittenger et al reported that only 
one-third of the initial adherent BM-MSCs clones are pluripotent 
(osteo/chondro/adipo) (Pittenger et al., 1999). Furthermore, non-
immortalized cell clones have been used to investigate the nature and 
properties of committed progenitors present in culture of BM-MSCs. This 
study demonstrated that 30% of all clones exhibited a tri-
lineage(osteo/chondro/adipo) differentiation potential, while the remainder 
displayed a bi-lineage (osteo/chondro) or uni-lineage (osteo)(Muraglia et 
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al., 2000). The heterogeneity, both in vivo and in vitro studies, could be 
explained by the notion that MSCs in the bone marrow are a pool of cells 
that include MSCs and different subpopulations at different state of 
differentiation. During in vitro culture, were isolated all or a subset of these 
MSCs. During differentiation, the proliferative potential of these different 
MSCs decreases and, depending on the initial state of differentiation, both 
proliferative and multilineage potential become limited (Baksh et al., 2004) 
(Fig.10). 
 
 
 
 
 
 
 
 
 
 
Fig.10: Models of MSCs differentiation; A) capacity to differentiate into all 
connective tissue cell types; B) MSCs population that with different 
differentiation potentials (Baksh et al., 2004) 
 
For the immunological profile, MSCs express intermediate levels of human 
leukocyte antigen (HLA) class I molecules major histocompatibility 
complex (MHC) and low levels of class II HLA and Fas ligand; they do not 
express the costimulatory molecules B7-1, B7-2, CD40, or CD40L. The 
immunosuppressive nature of MSCs is of clinical relevance in allogeneic 
transplantation since it could reduce the incidence and severity of graft-vs-
host disease (GVD) (Le Blanc et al., 2003 a, b). Clinically, the easy of 
isolation, expansion potential, migratory capacity and immunosuppressive 
capability of MSCs has made them a popular cell type for investigating 
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regenerative medicine, gene therapy and tissue engineering (Fig.11). 
Several studies based on animal transplantation, shown that ex-vivo 
expanded MSCs were able to differentiate into cells of the residing tissue, 
to repair damaged tissue and to restore partially its normal function, 
generating promising results for the treatments of several illness, including 
bone (Mauney et al., 2005), cardiovascular (Zimmet et al., 2005) and brain 
disease (Zimmet et al., 2005). Recent studies demonstrated that the 
therapeutic contribution of MSCs transplantation could be caused not only 
by direct differentiation but also by paracrine activities which supply with 
large amounts of cytokines and growth factors. These bioactive factors 
suppress the local immune system, inhibit apoptosis, and enhance 
angiogenesis (Caplan et al., 2006). MSCs are promising also for tissue 
engineering. Bioengineered structures with a defined shape made with 
biomaterials like collagen type I, fibronectin, alginate, polylactic acid and 
alginate can be combinated with MSCs, culturing in bioreactors, it could be 
possible to obtain tissue and organs (Stock et al., 2001) as reported in pre-
clinic animal model studies for the treatment of a large bone defects (Kon 
et al., 2000). 
 
 
 
 
 
 
 
 
 
Fig.11: Potential uses of Adult Stem Cells in regenerative medicine, cells 
therapy and drug screening.
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3. STEM CELLS NICHE 
 
It is well know that self renewal and pluripotentiallity are specific skills of 
adult stem cells, but the idea that extremely specialized external stimuli and 
microenvironment can affect the regulation of the specific stem 
characteristic brought several team to go in for it. Microenvironment are 
constituted by adult tissue-specific stem cell but also other kind of cells 
characterized by the present of adhesive molecules and extracellular matrix 
proteins, that have an important role in the space localization and 
organization, in fact it has also regulating functions to determinate stem 
cell differentiation into various kind of mature cells, replacing cells lost due 
to natural cell death (apoptosis) or injury,  safeguards against excessive 
stem cell production that could lead to cancer and to preserve a sufficient 
stock of stem cell for the future, infact, stem cells must periodically 
activate to produce progenitor or transit amplifying (TA) cells that are 
committed to produce mature cell lineages (Fig.12). 
 
 
 
 
 
 
 
 
 
 
     
Fig.12: Stem cells niches 
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The niche concept was introduced in 1978 by Schofield studies (Schofield 
1978); his team proved that microenvironment cells has a role in 
maintaining in a quiescent condition the hematopoietic stem cell, and 
suggest the presence of a “stem cell niche”. The idea of specialistic areas in 
the microenvironment seems to be supported by the production of grown 
factor in outline compartment (Gordon MY 2008). Stomal cells releases 
locally grown factors that bind extracellular matrix structures, in this way 
target cells recognized them by specific receptor (Gordon MY 2008). This 
mechanism permit to localize high concentration of specific grown factors 
in specific microenvironment areas. Several increasing studies had shown 
the present of a wide range of humoral factors, cytokines, chemokines and 
adhesive factors supporting adult stem cells. A recent hypothesis is that the 
regulating marrow stimulus is placed in a 3D organization to establish the 
“stem niches”. Niche can be defined as a spatial microstructure in which 
houses adult stem cells, which start self renewal activity interacting with 
external stimuli. Niche characteristics are here resumed: the number of 
stem cells in a niche is well-regulated; stem status depends on the 
interaction with other histologically different cells; stimuli produced by 
niches supply the molecular base for the interaction between cells, and 
allow the transduction of activator and inhibitor signals, presiding over the 
expansion of stem compartment and into a niche also a not stem cell can 
reach pseudo-stem characteristics. 
All those results suggest that stem niche not have only a structural role, but 
seems to have the intrinsic potential to lead the destiny of the cells in it. 
This hypothesis was supported by several researchers that during several 
studies identified different niches in different anatomic district.  
 
Human stem cells niches known fill today are: 
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3.1  HEMATOPOIETIC STEM CELLS NICHE  
 
The bone marrow contains multiple stem cell types, including HSCs and 
mesenchymal MSCs which have the ability to self-renew and to 
differentiate into cartilage, bone and adipose tissues at the single cell level 
(Pittenger et al., 1999). HSCs are the best characterized adult stem cell 
population. Single HSCs are multipotent, highly self-renewing, and cycle 
with slow kinetics. In adult bone marrow, a part of these HSCs are known 
to reside in two different niches, an “endosteal” niche and a “perivascular” 
niche. The endosteal niche it seems to maintain HSC in a long term 
quiescence whereas perivascular niche it seems to maintain the quiescence 
of HSCs for a shorter period, supporting HSC‟s proliferation, favoring 
myeloid and megakaryocytic lineage differentiation and mediating HSC‟s 
circulation (Perry et al., 2007). In the endosteal niche, HSCs are associated 
with a subset of osteoblasts that line the inner surface of trabecular bone 
cavities and giving arise to progenitors that migrate to blood vessels in the 
middle of bone marrow cavity where they mature and differentiate (Nilsson 
et al., 2001, Gong 1978, Heissig et al., 2002) (Fig.13a). Studies have 
shown that the position of osteoblast cells is a for the begin of the process 
as previously described (Zhang et al., 2003).The role of osteoblasts a 
support for HSC growth was suggested through in vitro coculture 
experiments (Taichman et al. 1994, 2000), and simultaneously using 
genetic mutant mouse models (Zhang et al., 2003, Calvi et al., 2003, Arai 
et al., 2004) was identified osteoblastic cells as a key component of the 
HSC niche.  Endosteal osteoblasts are thought to provide a several factors 
that regulate HSC number and function (Zhang et al., 2003, Calvi et al., 
2003). A possible mechanism by which osteoblasts would regulate the 
number of HSCs is through secretion of osteopontin that is a bone matrix 
glycoprotein that seems to maintain HSC in quiescence form and to 
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regulate HSC proliferation in a negative way. An increasing number of 
molecular studies point to the existence of a complex paracrine signaling 
network at the interface between the niche osteoblast and the adjacent 
HSCs; Kit ligand is expressed by osteoblasts and is able to activate Kit on 
HSCs surface. Notch signaling plays an important role in cell fate to 
maintain HSCs in an undifferentiated state (Calvi et al., 2003, Duncan et 
al., 2005, Varnum-Finney et al., 2000). Another important interaction is 
between the ligand angiopoietin-1 a the osteoblast surface and the receptor 
Tie-2 (Tyrosine kinase with immunoglobulin-like and EGF-like domains 2) 
expressed on HSCs, which has been shown to modulate HSC quiescence 
(Arai et al., 2004) (Fig.13b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.13: The Hematopoietic Stem Cells (HSCs) niche in the bone marrow. 
a) Schematic diagram of HSCs and niche cellular components in the bone 
marrow; b) Extrinsic signaling pathways that regulate proliferation and 
differentiation of HSCs (Li et al., 2005) 
a 
b 
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3.2  EPIDERMAL STEM CELLS NICHE 
 
Skin epidermis, with its appendix hair follicle structure, is a regenerating 
organ with a well-organized architecture. Each hair follicle is composed of 
a permanent portion, which includes sebaceous glands and the underlying 
bulge area, and a dynamic renewing portion which give arise two stem cells 
population within the hair follicle and interfollicular regions. The first 
population, the epidermal stem cell is located in the basal layer of the skin 
clustered in epidermal proliferation units (Potten 1981), normally gives rise 
to stratified skin layers. The second, hair follicle stem cells (HFSCs), 
resides in a region of the outer root sheath called the “bulge”, and it is 
responsible for the regeneration of hair and sebaceous glands, restore the 
epidermis after wounding (Taylor et al., 2000, Rendl et al., 2005) and that 
can be activated during the hair cycle in response to injury (Fig.14a). 
The bulge area act as a niche where HFSCs (Niemann et al., 2002) are 
located, maintained (Cotsarelis et al. 1990, Sun et al. 1991) and also 
responsible for the long-term replenishment of the interfollicular epidermis. 
Bulge stem cells are generally quiescent, multipotent and, after their 
activation, giving rise to daughter cells; the daughter cells retained in the 
bulge remain as stem cells while other daughter cells migrate down to 
become hair-matrix progenitors responsible for hair regeneration 
(Cotsarelis et al., 1990, Niemann et al., 2002,Oshima et al., 2001, Taylor et 
al., 2000). The multipotentiality of single HFSCs has been shown by using 
cells expanded in vitro. An in situ tracking method has shown that 
progenitors in the hair follicle contribute to single lineages and possess 
limited self-renewal potential, suggesting that it may be possible to 
measure various lineage potentials rigorously when and how they segregate 
after HFSCs activation (Legue et al., 2005). 
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The molecular analysis epithelial stem cells has revealed the following 
features: 1) the expression of adhesion molecules known to be involved in 
stem cell-niche interaction, 2) the presence of growth inhibition factors 
such as TGFβ/BMP molecules and cell cycle inhibitors, and 3) Wnt 
pathway including receptors and inhibitors such as Dkk, sFRP, and WIF is 
important in the hair follicle niche. Taken together, these molecular 
features indicate that the epithelial stem cell niche is a growth- and 
differentiation-restricted environment (Tumbar et al. 2004) (Fig.14b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.14: The Epidermal Stem Cells (ESCs) niche. a) Schematic diagram of 
the major types and spatial orientations of HSCs that make up the hair 
follicle; b) Interactive signaling pathways that mediate HFSC proliferation 
(Li et al., 2005) 
 
 
 
a 
b 
a 
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3.3  INTESTINAL STEM CELLS NICHE 
 
The intestinal epithelium can be divided into two regions, a region 
containing pericryptal fibroblasts and mesenchyme functional 
differentiated cells (villa), and a proliferative region (crypt Lieberkühn) 
which represents the stem cell niche. Intestinal regeneration begins with 
intestinal stem cells (ISCs), which give rise to four different types of 
epithelial lineages: columnar enterocytes, mucin-producing goblet cells, 
Paneth cells, and enteroendocrine cells (Bjerknes et al., 1999, et al., 1995, 
Winton et al., 2000) (Fig.15a).  
ISCs are generally proposed to be located at the fourth or fifth position 
from the crypt bottom, above the Paneth cells (Booth et al., 2000, He et al. 
2004, Sancho et al. 2004). The crypt is a contiguous pocket of epithelial 
cells at the base of the villus. ISCs and TA cells within the crypt regenerate 
the entire villus every 3 to 5 days (Potten et al., 1990). Genetic marker 
shows that crypts derive from an individual or few ISCs and that each 
villus is the product of cells the coming from several adjacent crypts 
(Gordon et al., 1992). There are four to six ISCs per crypt that are located 
in ring diameters of about four cells from the crypt bottom. Progeny of 
activated ISCs migrate upwards to become TA cells. When they reach the 
top of the crypt, TA cells stop proliferating and assume their appropriate 
positions within the villus structure.  
During postnatal intestinal regeneration, mesenchymal cells subjacent to 
epithelial cells play a role in epithelial cell proliferation, differentiation, 
and apoptosis; BMP4, expressed in the ISC-adjacent mesenchymal cells, is 
one of the putative niche signals (He et al. 2004); endothelial cells provide 
ISCs with survival signals such as fibroblast growth factor (FGF) (Paris et 
al. 2001); myofibroblasts surrounding epithelial cells, supported ISCs 
“niche” and influence other epithelial cells (Mills et al., 2001).  
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Molecular analysis showed that signal Wnt plays a positive role in the 
promotion of ISC activation/self-renewal; in contrast, BMP signaling 
restricts ISC activation/self-renewal and crypt cell fate (Haramis et al. 
2004, He et al. 2004) (Fig.15b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.15: The Intestinal Stem Cells (ISCs) niche. A) Schematic diagram of 
the major types and spatial orientations of cells found within the crypt 
niche and the villus. B) Interactive signaling pathways that mediate ISC 
proliferation (Li et al., 200)5 
 
 
3.4  NEURAL STEM CELLS NICHE 
 
In adult life, neurogenesis is possible in specific brain area where were 
identified and characterized neuronal niches. 
Neural stem cells (NSC) were identified in 1990 and then isolated from 
various regions in the adult brain and peripheral nervous system (Alvarez-
Buylla et al., 1990).The subventricular zone (SVZ) and the subgranular 
a 
b 
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zone (SGZ) of the hippocampus region are the primary and well-
characterized germinal regions in which NSCs reside and support 
neurogenesis in the adult brain (Doetsch et al. 1999, 2003, Lois et al. 1993) 
SUBVENTRICULAR ZONE (SVZ) is a single layer of multi-ciliated 
ependymal cells separates the SVZ from the lateral ventricle (LV). There 
are four main cell types in the SVZ: neuroblasts (Type A cells), SVZ 
astrocytes (Type B cells), immature precursors (Type C cells) and 
ependymal cells (Doetsch et al., 1997). In this region, the SVZ astrocytes, 
located adjacent to the ependymal cells, have stem cell features and give 
rise to TA precursor C cells. Infact, immature cells, deriving from SVZ 
astrocytes, are precursors of a group of neuroblasts which differentiate into 
neurons and migrate toward the olfactory bulb and other regions. SVZ 
astrocytes can also generate oligodendrocytes (Doetsch 2003, Mirescu et 
al., 2003, Temple 2001). Another noteworthy feature of this region is a 
specialized basal lamina, which extends from blood vessels in SVZ region 
and terminates in small bulbs adjacent to ependymal cells, and contacts all 
SVZ cell types. In SVZ are also present blood vessels and endothelial cells 
that lining the blood vessels and these are likely a source of signals for 
adult neurogenesis (Fig.16a).  
 
SUBGRANULAR ZONE (SGZ) is the germinal layer between the dentate 
gyrus and the hilus in the hippocampus and it is responsible for the 
generation of dentate gyrus granule neurons (Palmer et al. 1997). In the 
SGV region, neurogenesis occurs in foci closely associated with bloods 
vessels (Palmer et al. 2000). As in the SVZ, SGZ astrocytes acts as a stem 
cell; are the primary precursors of neurons and generate daughter cells that 
further produce granule neurons (Fig.16b). 
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Fig.16: The neural stem cell (NSC) niche. a) The subventricular zone 
(SVZ). Astrocytes (B) lining the ependymal cells (E) function as NSCs; 
they give rise to transient amplifying cells (C) (green), which further 
produce neuroblast cells (A); b) The subgranular zone (SGZ). Astrocytes 
(B) directly attach to the blood vessel and receive signals from the 
endothelial cells that direct NSCs to undergo self renewal, proliferation 
(D), and differentiation (G) (Li et al., 2005) 
 
 
In both regions, endothelial cells and the specialized basal lamina are 
essentials components of the NSC niche. The ECs provide attachment for 
SVZ and SGZ astrocytes and generate a variety of signals controlling stem 
cell self-renewal and lineage commitment (Doetsch 2003, Shen et al. 
2004). In fact, angiogenesis and neurogenesis may be co-regulated and 
reciprocally signaled. Both are stimulated by the same factors, including 
bFGF, VEGF, insulin-like growth factor (IGF-1) and TGF-a; ECs secrete 
well-known mitogens, differentiation and survival neuronal factors like 
bFGF, IGF-1, VEGF, PDGF, IL8 and brain derived neurotrophic factor 
(BDNF) (Palmer et al. 2000, Jin et al., 2002, Louissaint et al., 2000). 
a b 
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3.5 VASCULAR NICHE 
 
In 2006 was suggested the existence of a “vasculogenic niche” in the 
human vascular wall of large and mid-sized blood vessels. The existence of 
this “vasculogenic zone” has been defined as a vascular mural zone, 
identified in adult human vascular wall and located at the border between 
the media and the adventitial layers containing a complete hierarchy of 
resident stem cells, which may serve as a source for progenitor cells for 
postnatal vasculogenesis. This zone of vascular wall serves a niche 
containing the vascular wall-endothelial progenitor cells (VW-EPC) 
resident, which are capable of forming capillary sprout in arterial ring assay 
in vitro, outside the bone marrow, even if Ingram‟s group reported the 
existence of VW-EPCs but did not furnished the exact location within the 
vascular wall (Ingram et al., 2005) but also MSCs and probably also 
vascular wall hematopoietic progenitor cells (HPCs) (Fig.17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.17: Vascular niche 
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Moreover, this area could correspond to a vascular wall stem cell niche 
identified as special microenvironment in a strategic location at the 
interface between the media and adventitial layers, physiologically limited 
and specialized, an unexpectedly elevated cell proliferation under normal 
conditions, selective localization of cells expressing the stem cell surface 
molecules c-kit, in which stem cells and multipotent stromal cells stay; 
both cytotypes could contribute in maintaining post-natal vascular 
homeostasis replacing old or damaged elements/items (Pacilli et al., 2009). 
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4. VASCULAR WALL RESIDENT STEM CELLS 
 
In growing body several evidence suggests a close relation between 
hematopoiesis and vasculogenesis in vertebrates. During early 
embryogenesis, hematopoietic and endothelial lineages derive from 
aggregates of mesodermal cells that subsequently mature and form blood 
islands in the extra-embryonic yolk sac. These blood island consists of an 
inner core of blood cells and an external layer of endothelial cells 
(ECs)(Sabin 1920, Murray 1932) and the simultaneous presence of these 2 
kind of cells has led to the hypothesis that they originate from a common 
precursor called hemangioblast (Murray 1932).The formation of the blood 
islands in the yolk sac marks the begin of the vascularization in the 
developing embryo. Two different processes contribute to the formation of 
the vascular system. The first process, vasculogenesis, requires the 
differentiation of endothelial cells from hemangioblast and their subsequent 
organization into a primary capillary plexus (Risau et al., 1988, 1995) and 
it is restricted to early embryogenesis. The second process, angiogenesis, 
results in the formation of new vessels by sprouting from preexisting blood 
vessels (Folkman 1992, 1995) and occurs both during development and 
postnatal life. However, studies have showed that postnatal angiogenesis 
may occur by recruitment of bone marrow and peripheral blood and of 
endothelial progenitors cells (EPC), with property of embryonal angioblst, 
involved in the new blood vessel formation in response to various stimuli 
(Asahara et al., 1999a). Once mobilized from bone marrow and released 
into the circulating blood (CEPs), these progenitors are supposed to 
participate in physiological and pathological arterial wall remodeling 
during their lifetime (Carmeliet 2003). In fact, experimental evidences 
support the use of EPCs in angiogenic therapies or as biomarkers to assess 
cardiovascular disease risk (Rafii et al., 2003, Vasa et al., 2001, Kalka et 
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al., 2000, Kawamoto et al., 2001, Tepper et al., 2002). Although, EPC 
residing in the site of ischemia contribute, as has been demonstrated, to the 
formation of new vessels (Hristov et al., 2003). Recently, another group of 
vascular progenitor cells has been found abundant vascular in the adventitia 
of ApoE-deficient mice, in particular in the aortic root; these progenitors 
containing stem cell markers e.g. Stem cell antigen-1 (Sca-1+), c-kit+ 
CD34+ and fetal liver kinase-1 (flk-1+) but not SSEA-1+, contributed to 
experimental atherosclerosis and did not originate from the bone marrow 
(Hu et al., 2004). Moreover, the pool of mature human endothelial cells 
seams to contain a subpopulation of EPCs allegedly organized in a 
completely hierarchical manner with different clonogenic and proliferative 
potentials. Although various studies have identified other peripheral 
sources of EPCs including skeletal muscle (Majka et al., 2003), spleen 
(Wassmann et al., 2006), liver (Aicher et al., 2007), fat (Planat-Benard et 
al., 2004) and adventitial of the arterial wall, the best characterized source 
remains the bone marrow.  
Most of the knowledge about resident vascular progenitors comes from 
animal models. Tintut et al. first demonstrated that MSCs were also present 
in the adult animal vessels. They described and isolated a subpopulation of 
vascular cells with lineage plasticity and self-renewal capacity also known 
as Calcifying Vascular Cells (CVCs). This CVCs expressed surface 
markers commonly expressed by BM-MSCs like CD44 and CD29 while 
were absent hematopoietic antigens such as CD14 and CD45; these cells 
showed not only osteoblastic potential but also chondrogenic, leiomyogenic 
and stromogenic lineages and limited adipogenic potential under specific 
experimental conditions (Tintut et al., 2003). In 2006, it has been 
demonstrated the presence of resident precursors of endothelial and smooth 
muscle cells in healthy arteries of adult mices defined “side population” 
(SP) using flow cytometry method. The researchers selected the 
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progenitors in the medial tunica layer of thoracic and abdominal aortas, 
with phenotypic and functional progenitor cells properties, and then 
differentiated them with VEGF and TGF-beta1. This vascular plasticity 
suggests that the SP could allow a physiological renewal and could provide  
to a regeneration after injury by the rapid growth of new ESc and smooth 
muscle cells (SMCs) participating also in the homeostasis and remodeling 
processes (Sainz et al., 2006). Even though more recent studies provided 
informations about their presence and role in the human vascular wall.  
Resident vascular progenitor cells were also found in the human fetal aorta 
as demonstrated by Invernici‟s study. This immature vascular progenitors 
cells residing in the human fetal aorta are able to give rise to endothelial 
and mural cells in response to vascular endothelial growth factor (VEGF) 
and plateled derived growth factor beta (PDGF-BB) and are also able to 
improve the neovascolarization in a murine models of peripheral ischemia 
(Inverinci et al., 2007). The absence of a CD45 marker suggests that human 
vascular progenitor cells (hVPCs) may not have a hematopoietic origin but 
may derive from immature mesenchymal stem cells residing in niches 
located in the fetal paraortic membrane or in the peripheral parenchym 
aorta wall (Alessandri et al., 2001). 
A great contribution to assess the presence of EPCs in the adult vascular 
wall was provided by Zengin and his studies. His research group isolated 
vascular progenitors cells from the human internal thoracic artery wall 
(HITA), suggesting the existence of a “vasculogenic zone” as previously 
described, in the wall of large and mid-sized blood vessels, where might be 
found not only the VW-EPC but also a genuine hierarchy of resident stem 
cells including MSCs and probably resident vascular wall hematopoietic 
progenitor cells (HPCs) able to differentiate into ECs, local immune cells 
such as macrophage and HSCs as well as precursors of SMC, fibroblast and 
pericytes (Zengin et al., 2006). According with the hypothesis, several 
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experimental observations had shown that the same area in postnatal artery 
walls may contain MSCs with a multilineage differentiation. More recently, 
other groups found multipotent vascular resident MSCs in human vascular 
adventitia, pulmonary artery (Hoshino et al., 2008) and in the saphena vein 
(Covas et al., 2005). Our group described the presence of vascular wall 
resident mesenchymal stem cells (VW-MSCs) in normal human adult 
thoracic and femoral artery aortas from healthy and heart beating donors 
(Pasquinelli et al., 2007,2010). Cryopreserved thoracic aortas were 
harvested from heart-beating multi-organ donors and was evaluated the 
resistance of vascular wall cells (VWCs) to cryoinjury (Pasquinelli et al., 
2006, Pacilli et al., 2009); the majority of VWCs, i.e. EC and SMCs were 
irreversibly injured by cryopreservation procedures. Interestingly, the few 
stress-resistant cells in the cryopreserved arterial wall which survived after 
4 days of organ culture were localized near to the vasa vasorum, vascular 
structure CD34+, at the border between media and adventitia layers 
according to the vasculogenic zone previously described by Zengin; this 
cells were able to induce angiogenesis in ex vivo culture experiments. 
Furthermore, in the vasculogenic area, previously described by Zengin in 
HITA, was identified a double population CD34+ and c-kit+ with putative 
stem cells characteristics; immunohistochemical tissue analysis confirmed 
the presence of an analogous well-developed plexus of CD34+ small 
vessels in the aorta and in the femoral artery as well. Single 
immunostaining on serial sections supported the presence of CD45+ 
inflammatory cells that correspond to the resident CD34+/CD31- 
endothelial progenitors reported in HITA. Beside its assumed vasculogenic 
post-natal ability, this area could act as strategic for the recruitment of 
blood circulating cells. Again, additional experiments have also revealed 
the presence of CD68+ and S-100+ perivascular cells that represent 
resident macrophages and dendritic cells. In similar samples, we isolated a 
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cell population with analogous properties with bone marrow derived-
MSCs, demonstrating a strong angiogenic ability (Pasquinelli et al., 2007) 
and adipogenic, osteogenic, chondrogenic and leyomiogenic potentials. 
These VW-MSCs could be actively involved in the remodeling of the wall 
in both normal and development of ectopic tissue like cartilage, marrow 
and fat tissue in pathological conditions like vascular disease and 
atherosclerosis. 
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5. HOMOGRAFT 
 
The use of vascular prosthesis for the hemodynamic restore and recover 
and anatomic re-vascularization in surgery techniques for ateropathy is a 
serious problem that lead to a great scientific interest. The first experiment 
to rebuild a damaged artery was in 1774 (Callow 1982), in this year a 
medicine student from Paris, LeConte, used as a vascular prosthesis a duck 
feather segment; this approach was a failure because of the insurgence of 
infection loci, from that moment vascular research start to develop different 
kind of prosthesis. In the last XIX century, Masini in 1895 and Nitze in 
1897 had the idea to invaginate glass or avory cylinder in vessels that need 
to be repaired (Callow 1982). At the beginning of the XX century the use 
of homolog and natural prosthesis put the bases for the modern concepts of 
vascular surgery.  The homograft is a homologous prosthesis that offer the 
possibility to substitute arterial segments with transplanted homologous 
venous segments. The term homograft in literature was first mentioned by 
Carrel (Carrel 1912), who positioned homologous and xenologous 
prosthesis in dogs; later Goyanes used the poplitea vein to reconstruct the 
poplitea artery during a anurysmectomy (Goyanes 1906); the very first 
clinic procedure with homologous artery for the aortic aneurism was tanks 
to Gross (Gross et al., 1948), Oudot (Oudot 1953) and Dubost (Dubost et 
al., 1951). Since then the use of homograft has been considered a possible 
surgical treatment for stenotic and aneurysmal diseases of the aortic-iliac-
femoral vasculature (Odero et al., 2001). Unlikely those homografts lead to 
a structural degeneration provided with dilatations, rupture or thrombosis, 
becoming soon aneurysmal. Besides the low availability of autologous vein 
for their caliber, varicose and inflammation or previous sampling, lead the 
research to the development of new strategy to create synthetic vascular 
prosthesis and other therapeutic procedures less invasive. The introduction 
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in the „50s of synthetic prosthesis and their immediately encouraging short 
and long term results, clearly better than homografts one, bring to a 
temporary abandon of the last one. The introduction, in normal clinic 
techniques, of efficient blood anti-coagulative methods, of an adequate 
antibacterial therapy and the development of surgical techniques able for 
atherosclerosys treatment, after few years, in 1991, this technique was 
suggested again with completely different indications from those for which 
they had originally been proposed. France vascular surgeons of Pitié-
Salpètriére of Paris proposed the vascular homograft in patients who had 
infected prosthesis, representing the 2-3% of cases who had vascular 
prosthesic surgery mainly in aortic district (D'Addato et al., 1997), because 
the natural resistance to bacterial colonization makes the homograft an 
ideal candidate for the treatment of this infection. In fact the surgical 
treatment of this pathology, for its not simple solution, it can‟t be treat by 
reposition of a new prosthesis, because as a synthetic material (Vinyon N, 
Nylon, Teflon, Orlon e Dacron) could be a fertile ground for the 
regeneration of the infection and for the targeted antibiotic treatment, even 
in loco, can give some results in low microbic infections. Arterial 
homograft represents the surgical treatment of choice for this complication, 
because the use of homolog arteries guarantees the ill from the infection 
being able to permit an anatomic re-vascularization. Samples, from multi 
organ donors, were readily implanted or stocked at 4° in RPMI buffer 
(culture cells buffer) for not more than 30 days (Bahnini et al., 1991, 
Kieffer et al., 1993, Koskas et al., 1996) but the need of arterial segments 
used in normal clinic practice increased. So in 1990 were found in Europe 
the Cardiovascular Tissues Banks, structures responsible for the process of 
preservation, certification and distribution of tissues, offering the 
possibility to have homografts of various diameter or length in case autolog 
material will be not available or usable. Recently AOCP and abdominal 
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aortic aneurysm have been inserted in the pathologies treatable with this 
procedure. Often the homgrafts are unsatisfactory and the major 
inconvenient seems to be the immune reaction (caused by the resistance of 
cells to the cryopreservation process). Even in the existent literature, a very 
low interest has been given to the immune response of the receiver treated 
with vascular homograft caused by prosthesis infection, this because 
vessels are considered low antigenicity tissues. Moreover a lot of author, in 
clinical practice, don‟t respect\contemplate any compatibility between 
donor and receiver, neither for blood group (ABO compatibility) or 
eventual antibodies preexistent in the receiver serum (cross-match). It was 
documented that vascular wall cells, like endothelial ones and other like 
smooth muscle cells and fibroblast express both antigens of blood group 
(A, B, 0 groups) and major histocompatibility antigens, known as HLA 
(Human Leukocyte Antigens) able to active the immunological response 
rejection (Pober et al. 1986).  In reality, some clinical studies reported late 
complications of the homografts referred to episodes of   chronic reject 
(Ruotolo et al., 1997). In particular the same French school documented, in 
the 25% of treated cases, episodes of chronic reject like miointimal 
hyperplasia, necrosis of muscular tunic and adventitial inflammatory 
infiltration. In fact the first consequences of receiver‟s immunological 
reaction are preceded by a rapid disappearance of immunological 
endothelial cells, first target of the direct attack (cytotoxic). Later disappear 
gradually smooth muscle cells, attacked mainly by an antibody mechanism, 
that cause the thinner of the medial tunica. The last phase of the reject 
process is characterized by a miointimal proliferation, composed by the 
cells of the receivers (Fig.18b). Functionally, in large caliber vessels the 
necrosis of the media, its thinner and the substitution with fibrotic tissue 
that predispose the insurgence of the aneurysmal dilation. In the contrary, 
in small caliber vessels, the miointimal hyperplasia is responsible of a 
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decrease of the lumen. To conclude, arterial homograft are immunogenic 
and induce in the receiver a specific cellular and humoral immunological 
reaction responsible of reject episodes. For this reason, it is necessary to 
respect the compatibility of at least blood groups and perform the transplant 
without the present of preformed anti HLA antibodies in receiver serum 
(negative cross-match). 
 
 
   
Fig.18: Schematic representation of vascular wall remodeling. a) Normal 
artery wall. b) Proliferation myointimal into vascular wall homograft. c) 
Signals pattern of wall remodeling.
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6. AIM OF THE WORK 
 
Stem cell research is one of the most fascinating field of contemporary 
biology, in particular, Adult Stem Cells that thank to their stem 
characteristic offer a possible therapeutic application in the regenerative 
medicine and tissue engineering. Adult Stem Cells reside in a “niche”, a 
special microenvironment, present in different tissues including blood 
vessels and provide to maintain the homeostasis of the tissue. 
Many studies demonstrated that the artery wall is a recipient and a source 
of Mesenchymal Stem Cells (MSCs)  that can differentiate along multiple 
lineages, and can probably useful as a source of cells for postnatal 
vasculogenesis. In adult human wall, of large and mid-sized blood vessels, 
was identified a “vasculogenic zone” between the smooth muscle and the 
adventitial layers, containing a complete hierarchy of resident stem cells. In 
this hypothetical “vascular niche” could be reside MSCs capable of 
differentiating into ECs, local immune cells such as macrophage and HSCs 
as well as precursors of SMC, fibroblast and pericytes (Zengin et al., 2006) 
(Fig.19).  
 
 
 
 
 
 
 
 
         Fig.19: The “ Vasculogenic zone” in the arterial wall (Zengin et al., 2006). 
 
According with the hypothesis, several experimental observations shown 
that the same area in postnatal artery wall may contain MSCs with 
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multilineage differentiation. Recently, our group identified, in normal 
human adult thoracic aortas and femoral arteries from young and healthy 
heart-beating multi-organ donors, the vasculogenic zone previously 
described by Zengin using immunoistochemical staining (Fig.20); we also 
isolated and described the presence of resident MSCs (VW-MSCs) with 
angiogenic ability (Pasquinelli et al., 2007) and multilineage potential 
(Pasquinelli et al. 2010) that present features similar to the mesenchymal 
stromal cells in bone marrow. 
 
 
 
 
 
 
 
 
Fig.20: “Vasculogenic zone” at the border between adventitia e media 
layers. a) CD34 positive cells; b) C-kit positive cells (Pasquinelli et al., 
2007 a). 
 
The aim of this work was to identify and localize in situ, with 
immunoistochemical analysis, the adult stem cell populations that could be 
reside in the vasculogenic zone and to understand their role in the vascular 
wall remodeling in failed homograft. Subsequently, we isolated this cell 
population and tested in vitro their multilineage differentiation potential 
through immunohistochemical, immunofluorescence, RT-PCR and 
ultrastructural analysis. The study of VW-MSCs could elucidate the 
pathological mechanisms of vascular aneurysms and may be useful for the 
development of new therapeutic strategies. For all those experiments, we 
used pathological vascular wall homografts.  
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7. MATERIALS AND METHODS 
 
7.1 ORGAN CULTURE  
 
Organ culture of the vessel wall is a useful in vitro method to study 
vascular cell biology preserving the in vivo anatomic relationships; the 
complex-three-dimensional organization in a more natural 
microenvironment. Besides, the organ culture offers an intermediate model 
in which the cells are those naturally forming the tissue, with their cell-cell 
and cell-extracellular matrix relationship (Wilson 1996, Jeremy1997, 
Porter1996), morphology and functions of differentiated cells. 
(Yamawaki1999 e 2000, De Mey 1989). 
This experimental procedure let study whether undifferentiated cells like 
putative resident vascular progenitors, are able to resist to chemical and 
physical stresses, to participate in vascular remodeling in a 3D model 
without any contributes of hematopoietic cells and whether these cells are 
able to develop inner/outer cell linings in long-term cultures without VEGF 
stimuli. 
 
7.1.1  Organ culture procedure 
 
A 12 cm-long fresh femoral artery was collected from a heart-beating 
donor at Cardiovascular Tissue Regional Bank of General Hospital S. 
Orsola - Malpighi of Bologna, and maintained for 72 hours in an antibiotic 
mixture (mefoxin 240mg/ml, lincomycin 120mg/ml, colimycin 100mg/ml, 
vancomycin50 mg/ml); after decontamination, random samples were 
processed for LM and TEM. The remaining tissue was washed in a sterile 
physiological solution, cut in 3x3 mm slices, and placed random into 
individual wells of 12-well culture plates containing basal medium DMEM 
supplemented with 5% FBS and antibiotic (100 U/ml penicillin and 100 
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µg/ml streptomycin) and cultured for up 70 days. Tissues were incubated at 
37°C in an atmosphere of 95% air and equilibrated with 5% C02; culture 
medium was exchanged with fresh medium every 3 days. At intervals of 
seven days, samples were recovered in triplicates and cut into three 
additional segments for histological, immunohistochemical and 
ultrastructural analysis. 
 
7.1.2 Histological analysis 
 
At the end of the culture period, each femoral artery segment was removed 
from the culture dish and a ring of each organ culture segment of femoral 
artery was processed for histological analysis. Thereafter, sample was fixed 
by immersion in 10% formaldehyde solution, embedded in paraffin to 
obtain 3µm-thick vessel sections to use for histological staining. In the 
fields of histology, pathology, and cell biology, fixation is a chemical 
process by which biological tissues are preserved from decay, either 
through autolysis or putrefaction. The purpose of fixation is to preserve a 
biological sample as close to its natural state as possible; acts to disable 
intrinsic biomolecules, such as proteolytic enzymes, which would 
otherwise digest or damage the sample; protect the sample from extrinsic 
damage such as bacteria which might exist in a tissue sample or which 
might otherwise colonize the fixed tissue and preserve the morphology of 
the sample as it is processed for further analysis. Subsequently, sample 
fixed was washed and dehydrated by passing the tissue through a series of 
increasing alcohol concentrations to remove all traces of water. The block 
of tissue was transferred sequentially to 70%, 96%, and 100% alcohols for 
3x5 minutes each. After dehydration, the tissue can be embedded in 
paraffin but first clear the tissue with xylol that is an intermediate fluid that 
is miscible with ethanol and paraffin. 3µm-thick homograft of artery wall 
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sections was obtained with microtome. For conventional histopathological 
analysis the sections were stained with hematoxylin & eosin (H&E) 
according to the histological procedures and observed with light 
micsroscope (LM). The staining method involves application of the basic 
dye hematoxylin, which colors basophilic structures with blue-purple hue, 
and alcohol-based acidic eosin Y, which colors eosinophilic structures 
bright pink. Images were digitalized through a video camera (JVC 3CCD 
video camera, KY-F55B, Jokohama, Japan) connected with a Leitz Diaplan 
light microscope (Wetzlar, Germany); original images were taken at 
magnificatio10X-20X analyzed using the Image-Pro Plus
®
 6 software 
(Media Cybernetics, Inc., Bethesda, MD, USA). 
 
7.1.3 Vascular wall remodeling: immunohistochemical analysis 
 
At the end of the culture period, each femoral artery segment was removed 
from the culture dish, fixed in 10% buffered formalin and embedded in 
paraffin. Four-µm-thick sections were used for immunohistochemical 
studies to localize vascular wall-MSCs in situ involved intovascular wall 
remodeling using antibodies (Abs) directed against molecules commonly 
expressed by MSCs.The slides were processed according to the non-biotin-
amplified method with kit reagents (NovoLink
TM
 Polymer Detection 
System, Novocastra Laboratories Ltd., Newcastle Upon Tyne, United 
Kingdom). Briefly, sections of vessels were deparaffinated, rehydrated 
through decreasing concentrations of ethanol (from 100% to 70%) and 
rinsed in distilled water. Then, the specimens were subjected to an antigen 
retrieval treatment to enhance antigenicity and allow epitope unmasking 
with citrate buffer pH=6.0 at 120°C, 1atm for 21 minutes. After cooling 
and washing, the endogenous peroxidase activity of the tissue was 
quenched for 10 minutes at rt with 3% hydrogen peroxide solution in 
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absolute methanol in the dark. After washing with Tris Buffered Saline 
(TBS) 1X, the slides were blocked with Novocastra
TM
 Protein Block for 5 
minutes in a wet chamber to reduce the non-specific binding of primary 
antibody and polymer reagent and rinsed twice with TBS 1X. Successively, 
the samples were incubated with primary antibodies diluited in 1% BSA in 
PBS over night (o.n.) at 4°C. Vascular tissue sections were stained using 
moAbs against CD34 (1:80, clone QBEND-10, Dako Cytomation); CD31 
(1:50, clone JC70A, Dako Cytomation); α-SMA (1:9000, clone 1A4, 
Sigma); Desmin (1:600, clone D33, Dako Cytomation); CD44 (1:100, 
clone G44-26, BD Pharmigen); CD90 (1:100, BD Pharmigen); CD105 
(1:50, clone 266, BD Pharmigen); Vimentin (1:260, clone V9, Dako 
Cytomation); STRO-1 (1:100, R&D System); Mast Cell Tryptase (1:50, 
Dako Cytomation) and pAbs was used to reveal c-Kit (CD117, 1:200, Dako 
Cytomation). After washing, the slides were further incubated for 30 
minutes at rt with Novocastra
TM
 Post Primary Block to enhance penetration 
of the next polymer reagent, rinsed in TBS 1X and after that incubated with 
NovoLink
TM
 Polymer for 30 minutes at rt. After washing, the enzyme 
activity was visualized with 3,3‟-diaminobenzidine (DAB), as substrate, 
prepared from Novocastra
TM
 DAB Chromogen and NovoLink
TM
 DAB 
Substrate Buffer, rinsed in distilled water to stop the reaction and 
counterstained with Gill‟s hematoxylin. Subsequently, the samples were 
dehydrated, coverslipped and viewed in a light microscopy using the 
Image-Pro Plus
®
 6 software (Media Cybernetics, Inc., Bethesda, MD, 
USA). Images were digitalized through a video camera (JVC 3CCD video 
camera, KY-F55B, Jokohama, Japan) connected with a Leitz Diaplan light 
microscope (Wetzlar, Germany). Original images were taken at 10X. 
Negative control consisted of omission of primary antibody from sections. 
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7.1.4 Ultrastructural analysis: TEM 
 
Femoral organ culture samples were washed with phosphate-buffered 0,15 
mol/L and fixed in 2.5% buffered glutaraldehyde and processed for TEM. 
Vascular tissue were rinsed in phosphate buffer, post-fixed in 1% buffered 
Osmium Tetroxide to preserve the lipid structures and cell membranes for 1 
hour at rt. They were then washed, dehydrated in a graded series of ethanol 
from 70% to 100% (3x10 minutes each at rt) and immersed in propylene 
oxide (2x15 minutes at rt) and then embedded in epoxy resin (50% Araldite 
CY12 + 50% Araldite HY + 1,5% Benzyldimetylammina (BDMA) as 
accelerator; all purchased from TAAB, England). The semi-thin sections 
obtained with ultramicrotome were stained with Toluidine blue. Ultrathin 
sections were cut with diamond knives using an ultramicrotome, 
transferred to specimen support grids, counterstained with uranyl acetate 
and lead citrate and observed in a Philips 400T trasmission electron 
microscope. 
 
 
7.2  PATHOLOGICAL CASES: HUMAN ARTERIAL HOMOGRAFT 
 
In this study were analyzed small segments of pathological arterial walls 
(aneurysmal yolk of abdominal aortas and failed homograft of femoral 
artery) removed and harvested\ by the Vascular Surgery team of the 
S.Orsola-Malpighi General Hospital of Bologna during routine surgery. 
Two posterior left femoral-tibial homograft segments were explanted from 
healthy male patients (mean age 70 years) after 3 year from their placement 
due to a preexisting aneurysmal dilation partially thrombotic. 
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7.3  HISTOLOGICAL ANALYSIS 
 
A ring of homograft segment of femoral artery was processed for 
histological analysis. Briefly, sample was fixed by immersion in 10% 
formaldehyde solution, washed and dehydrated by passing the tissue 
through a series of increasing alcohol concentrations (70%, 96%, and 
100%) and embedded in paraffin to obtain 3µm-thick homograft of artery 
wall section. This sections cut with microtome, stained with hematoxylin & 
eosin (H&E) for conventional histopathological analysis according to the 
histological procedures and observed with light micsroscope (LM). Images 
were digitalized through a video camera connected with light microscope; 
original images were taken at magnificatio10X-20X analyzed using the 
Image-Pro Plus® 6. 
 
 
7.4  “VASCULOGENIC ZONE”: IN SITU 
IMMUNOHISTOCHEMICAL ANALYSIS 
 
Four µm-thick dewaxed homograft sections were used for 
immunohistochemical studies; to localize vascular wall-MSCs in situ was 
assessed using antibodies (Abs) directed against CD90, CD44, CD105 and 
CD166 antigens, molecules commonly expressed by MSCs. The slides 
were processed according to the non-biotin-amplified method with kit 
reagents (NovoLink
TM
 Polymer Detection System, Novocastra Laboratories 
Ltd., Newcastle Upon Tyne, United Kingdom). Details of the procedures 
here used were similar to reported elsewhere (see paragraph 7.1.3). 
Vascular tissue sections were stained using moAbs against CD44 (1:100, 
clone G44-26, BD Pharmigen); CD90 (1:100, BD Pharmigen); CD105 
(1:80, clone 266, BD Pharmigen) and CD166 (1:100, clone 3A6, BD 
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Pharmigen). To detect the antigen/antibody reaction, the diaminodenzidine 
was used as chromogen. The immunohistochemical reaction was viewed in 
a light microscopy using the Image-Pro Plus
®
 6 software (Media 
Cybernetics, Inc., Bethesda, MD, USA). Images were digitalized through a 
video camera (JVC 3CCD video camera, KY-F55B, Jokohama, Japan) 
connected with a Leitz Diaplan light microscope (Wetzlar, Germany). 
Original images were taken at 10X and 20X. Negative control consisted of 
omission of primary antibody from sections.  
 
7.5  ISOLATION AND CELL CULTURE  
 
Fresh homografts of femoral artery were furnished by operating room of 
Vascular Surgery of the S.Orsola-Malpighi General Hospital of Bologna 
for the vascular stem cells isolation. Each fresh homograft segment, 
approximately 5-cm-long, was longitudinally cut, providing an exposed 
surface area measuring about 25-30 cm
2
 and washed with saline solution 
under a laminar flow. The harvested homograft segments were 
mechanically minced with a scraper and enzymatically digested with 
0.3mg/ml liberase type II (Roche, Milan, Italy) in Dulbecco‟s Modified 
Eagle Medium (DMEM) serum free (Lonza, Basel, Switzerland) for 30 
minutes at rt (Fig.21). 
 
 
 
 
 
 
 
Fig.21: Isolation of stem cell in the vascular wall homograft. a) Mechanic 
scaper; b) Enzymatic digestion 
a b 
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Each minced tissue was subsequently incubated with the same 
concentration of Liberase type II at 37°C in 5% CO2 humified atmosphere 
for other 30 min and subsequently at 37°C for other 4 hours using a rotor 
apparatus. After digestion, the homogenate was recovered,  filtered through 
a 100-70-40-µm nylon mesh cell strainer (Becton Dickinson; Franklin 
Lakes, NJ), pelleted, counted with Neubauer hemocytometer and seeded at 
1x10
6
/cm
2
 on collagen-I coated 12-well plates with DMEM supplemented 
with 20% heat inactivated fetal bovine serum (FBS; Lonza) and antibiotics 
(100 U/ml penicillin and 100 µg/ml streptomycin)   and subsequently 
incubated  at 37°C in a humified atmosphere with 5% CO2.  Nonadherent 
cells were removed after 72 hours by washing with PBS (Phosphate Buffer 
Saline). Culture media was changed every 3 days until testing. When cells 
were near confluence (approximately 1-2 weeks),  they were detached with 
0.25% trypsin-EDTA (Sigma, Milan, Italy), replated at a density of 5.000-
6.000 cells per cm
2
 of surface area as passage 1(P1), maintained in DMEM 
supplemented with 10% FBS and subcultured for up to P10-P12 for 
expansion and in vitro analysis. 
 
 
7.6  IMMUNOPHENOTYPING: FLOW CYTOMETRY ANALYSIS 
 
The immunophenotype of each homograft-mesenchymal stem cells (H-
MSCs) was investigated with flow cytometry that is able to analyze several 
thousand cells every second, in "real time," and can actively separate and 
isolate cells having specified phenotype. To detect surface antigen, cells 
taken at P3-P5 were washed twice with PBS containing 2% FBS and 
incubated for 20 minutes a rat using the following extensive conjugated  
monoclonal antibodies (moAbs) panel: anti-CD29-fluorescein 
isothiocyanate (FITC), anti-CD31-phycoerythrin (PE), anti-CD34-PE, anti-
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CD146-PE, anti-CD44-FITC, anti-CD45-allophycocyanin (APC), anti-
CD73-FITC, anti-CD90-phycoerythrin-cyanine 5 (PC5), anti-CD105-PE, 
anti-CD117-FITC (all from Beckman Coulter, Fullerton, CA, USA), anti-
CD133-PE (Milteny Biotech, Bologna, Italy) von Willebrand Factor (vWF, 
clone F8/86, Dako Cytomation, Glostrup, Denmark), anti-KDR (Sigma), 
anti-NG2 (R&D System, Inc., MN, USA), anti-STRO-1 (clone STRO1, 
R&D System), anti-Notch-1 (clone C-20, Santa Cruz Biotecnology, Santa 
Cruz, CA, USA), anti-Oct-4 (clone C-10, Santa Cruz Biotecnology) and 
anti-Sca-1 (clone CT-6A/6E, Cederlane Laboratories). The following 
secondary moAbs were used after cell staining with unlabeled primary 
moAbs: anti-mouse IgG-APC (Beckman-Coulter), anti-rabbit IgG-FITC 
(Dako Cytomation). To reveal vWF and Oct-4, the cells were fixed and 
permeabilized with the IntraPep Kit (Beckman-Coulter) and subsequently 
incubated with anti-mouse IgG-FITC (Dako Cytomation). Negative 
controls were performed using appropriate conjugated irrelevant 
antibodies. Samples were analyzed using a Cytomics FC500 flow 
cytometer equipped with two lasers for data acquisition (Beckman 
Coulter). Results were analyzed using the CXP Software (Beckman 
Coulter). 
 
 
7.7 IMMUNOFLUORESCENCE ANALYSIS 
 
To detect, also, intracytoplasmatic antigens, aliquots of H-MSCs were 
stained by moAbs using an immunofluorescence staining. Cells taken at the 
same passage used in the flow cytometry analysis were plated at 1x10
3
/cm
2
 
in collagen biocoated slide chambers (BD Bioscence) and then cultured 
until near confluence. The slides were fixed in 2% paraformaldehyde in 
PBS for 6 minutes at rt. For investigate the expression of 
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intracytoplasmatic antigens, cells were permeabilized with 0,5%Tryton X-
100 added during fixation. The slide chambers were incubated in a 
blocking solution containing 1% bovine serum albumin (BSA) for 30 
minutes at rt in a wet chamber to reduce non-specific staining and then, 
remove the exceeding blocking solution from slide without washes. After 
that, the H-MSCs were labeled at 37°C for 45 minutes with anti-human 
mouse moAb diluited in 1% BSA in PBS as follows: anti calponin (CALP, 
1:40, Dako Cytomation), anti H-caldesmon (CALD, 1:75, Dako 
Cytomation), anti PDGF-rβ (1:200, R&D System, Inc.), anti-α-Smooth 
Muscle Actin (α-SMA,  1:9000, clone 1A4, Sigma); anti-Desmin (1:600, 
clone D33, Dako Cytomation); anti-Vimentin (1:260, clone V9, Dako 
Cytomation,) and ki-67 (1:100, Novocastra ).After repeated washing in 
PBS, the cells were incubated with polyclonal rabbit anti-mouse 
immunoglobulins FITC-conjugated (fluoresceine isothiocyanate, 1:250, 
Dako Cytomation) secondary antibodies in 1% BSA in PBS for 45 minutes 
at 37°C in the dark. Finally, after several rinses to remove the secondary 
antibodies unlabeled, the samples were coverslipped with Pro long anti-
fade reagent with DAPI (Molecular probes, Milano, Italy). The nuclei were 
counterstained with 4‟,6-diamidino-2-phenylindole (DAPI) using the kit 
citated above. Sample were observed under a Leica fully automated 
inverted fluorescence microscope DMI6000 B using a DAPI filter (Leica 
Microsystems, Milan, Italy) and Original images were taken at 10X. For 
negative control, the sections were processed omitting the primary 
antibody, and no signal was detected. 
 
 
7.8  ULTRSTUCTURAL ANALYSIS: TRANSMISSION ELECTRON 
MICROSCOPY (TEM) 
 
Experimental Design – Materials and Methods 
- 60 - 
 
The subcellular characteristics of cells were investigated by transmission 
electron microscope (TEM). The P4 H-MSCs isolated from pathological 
segment were washed with phosphate-buffered 0,15 mol/L and fixed in 
2.5% buffered glutaraldehyde directly in culture plate for 10 minutes at rt. 
After scarper, the recovered cells were pelleted in an eppendorf tube, fixed 
again for 24 hours at 4°C and processed for ultrastructural analysis using 
the procedure as previously described (see paragraph 7.1.4). The semi-thin 
sections obtained were stained with Toluidine blue. Ultrathin sections were 
cut, transferred to specimen support grids, counterstained with uranyl 
acetate and lead citrate and observed in a Philips 400T trasmission electron 
microscope. 
 
 
7.9  STEM CELL GENE EXPRESSION: RT-PCR 
 
In previous studies (Pasquinelli et al., 2007, 2010), we had already shown 
that VW-MSCs isolated from multidistrict human vessels an constitutively 
expressed the embryonic stem cell marker Oct-4, molecules involved in 
stem cell critical regulatory pathways, i.e., c-kit, Notch-1, breast cancer 
resistance protein (BCRP-1), BMI-1, SOX-2, Oct-4, CD133 and KDR. 
Now, we investigated which regulation pathways are predominantly 
expressed in H-MSCs among them by reverse trascriptase-polymerase 
chain reaction (RT-PCR).  
The PCR is a technique to amplify a piece of DNA generating thousands to 
millions of copies of a particular DNA sequence. The method relies on 
thermal cycling (20-40 cycles and each cycle typically consists of 2-3 
discrete temperature steps), consisting of cycles of repeated heating and 
cooling of the reaction for DNA melting and enzymatic replication of the 
DNA. Primers (short DNA fragments) containing sequences 
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complementary to the target region along with a DNA polymerase (after 
which the method is named) are key components to enable selective and 
repeated amplification. As PCR progresses, the DNA generated is itself 
used as a template for replication, setting in motion a chain reaction in 
which the DNA template is exponentially amplified. PCR consists various 
steps (Fig.22): 
 
- Initialition step 
- Denaturation step  
- Annealing step 
- Extension/Elongation step 
- Final elongation  
- Final hold 
 
 
 
 
Fig.22: Schematic representation of various steps into Polymerase Chain 
Reaction 
 
Briefly, total RNA was extracted from H-MSCs from P4 using the RNA 
extracting reagent TRI reagent (Ambion Applied Biosystems, Austin, TX, 
USA) according to the manufacturer‟s instructions. The cells were 
homogenized in TRI Reagent solution, collected in an eppendorf and 
incubate for 5 minutes at rt. After that, the homogenate were centrifuged,   
incubated with 100 μl BCP 10 minutes at rt to generate the phase 
separation, recentrifuged again and the aqueous phase containing the RNA 
was transferred in a fresh tube. The RNA was precipitated by adding 
isopropyl alcohol, incubated at rt for 10 minutes, spinned to allowed RNA 
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to precipitate. After discard the supernatant, the gel-like bottom RNA was 
washed in 75% alcohol for washing, centrifuged, air-dried for 3-5 minutes, 
dissolved in DEPC water and quantified using Nanodrop. 
The quality of RNA extract was evaluated measuring the A260/A280 ratio. 
Reverse transcription reactions were performed in a 40 μl volume with 4 μg 
of total RNA and the RT-PCRs with 1µl of this solution.  
Reverse trascriptase (RT) program was: 
- annealing 25°C for 10 minutes 
- extension 37°C for 120 minutes 
PCR was performed with 1μl of cDNA which was amplified with specific 
primers and GoTaq
® 
Hot Start Polymerase Promega in PCR reaction mix 
PCR program used was: 
- denaturation step 94°C for 2 minutes 
- denaturation step 94°C for 1 minutes 
- annealing: variable foe each primer used for 1 min 
- elongation/extension step 72 °C for 1 minutes 
- final extension step 72°C for 5 minutes 
- refrigeration step +4°C 
Each cycle was repeated for 35-40 times. PCR primers are listed in table 
below (Table1) and were purchased from Invitrogen (Invitrogen Life 
Technologies, Inc.); RT reagents were furnished by Ambion Applied 
Biosystems and PCR reagents by Qiagen (Milan, Italy). The PCR products 
were separated by electrophoresis on a 2% agarose gel with 1x Tris-
acetate-EDTA buffer, stained with ethidium bromide and photographed 
under ultraviolet light (UV). 
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Table1: PCR primers sequence, annealing temperature and amplicon 
length for each gene used to quantify the stemness gene expression  
 
 
7.10  PROLIFERATION ASSAY: ALAMAR BLUE  
 
Cell proliferation was assessed by Alamar Blue™ assay (BioSource, 
Camarillo, CA), a nontoxic aqueous dye, formulated in order to quantify 
cell proliferation directly in vivo. In brief, the medium was removed from 
the H-MSC cells in culture at day 1, 4, 8, 10, 14, 18 and 21 and they were 
incubated at 37°C for 4 hours with 1 ml of Alamar Blue™ solution (10 % 
v/v in complete cultured medium) according to manufacturer‟s instructions. 
Alamar Blue™ reduction was quantified by measuring the fluorescence of 
100 µl of incubated solution in triplicate from each sample (Ex 540/Em 590 
nm) using a Wallac VICTOR
2 
multiplate reader (Perkin Elmer, Milan, 
GENE Primers Sequence Amplicon 
lenghth (bp) 
Ta°C 
Oct-4 REV   5‟-CCACATCGGCCTGTGTATAT-3‟ 
FW  5‟-CTCCTGGAGGGCCAGGAATC-3‟ 
380 
 
60 
BMI-1 REV 5‟-CATTGCTGCTGGGCATCGTAAG-3‟ 
FW5‟GGAGACCAGCAAGTATTGTCCTTTTG-3‟ 
369 62 
BCRP-1 REV 5‟-CTGAGCTATAGAGGCCTGGG-3‟ 
FW 5‟-GTTTATCCGTGGTGTGTCTGG-3‟ 
652 60 
CD133 REV5‟GTACAACACTACCAAGGACAAGGCGT3‟ 
FW 5‟-CTGGGGCTGCTGTTTATTATTCTG-3‟ 
337 62 
KDR REV 5‟ TTTGTCACTGAGACAGCTTGG-3‟ 
FW 5‟ TATAGATGGTGTAACCCGGA-3‟ 
555 62 
c-kit REV 5‟ CATACAAGGAGCGGTCAACA-3‟ 
FW 5‟ GTCTCCACCATCCATCCATC-3‟ 
275 57 
SOX- 2 REV  5‟-GCGCCGCGGCCGGTATTTAT-3‟ 
FW   5‟-ACCGGCGGCAACCAGAAGAACAG-3‟ 
208 60,5 
Notch-1 REV 5‟-TGGCATCAGCTGGCACTCGTCC-3‟ 
FW 5‟-CCGGCTGGTCAGGGAAATCGTG-3‟ 
496 62 
β2-µglobulin REV 5‟-ATCTTCAAACCTCCATGATG-3‟ 
FW 5‟-ACCCCCACTGAAAAAGATGA-3‟ 
114 58 
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Italy). Subsequently the cells were re-fed with fresh medium without dye. 
For continual assessment of cell proliferation, the Alamar Blue™ assay 
was performed every 2-3 days on the same cell population for up to 21 
days. Unpaired t-test was used to evaluate statistical differences between 
mean values. 
 
 
7.11  IN VITRO MULTILINEAGE CAPACITY 
DIFFERENTIATION 
 
Since the cells were isolated from vascular wall homograft, as they showed 
a phenotype coherent with those described for mesenchymal stromal cells 
in bone marrow, we investigated their multipotency. In that regard, H-
MSCs were induced to differentiate into angiogenic, osteogenic, 
adipogenic and chondrogenic (to check the attribute of mesenchymal stem 
cells) and also leyomiogenic, because smooth muscle cell is a cytotype 
present into vascular wall of blood vessels. 
 
 
7.12 ANGIOGENIC DIFFERENTATION  
 
To estimate the angiogenic capacity of H-MSCs induced, an analysis of 
capillary formation was performed according to Oswald (Oswald et al., 
2004) using the in vitro angiogenesis assay kit (Chemicon, Temecula, CA). 
That is a convenient system for evaluation capillary-like structures 
formation. In fact, endothelial cells when cultured on ECMatrix rapidly 
align themselves and form hollow tube-like structures. Cells taken at P4  
were cultured until near confluence for 7 days in DMEM plus 2% FBS with 
and without 50 ng/ml VEGF (Sigma) as well as in DMEM plus 10% FBS 
(negative control).   
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Vascular endothelial growth factor (VEGF) is a sub-family of growth 
factors produced by cells that stimulates the growth of new blood vessels 
during embryonic development, after injury and collateral circulation to 
bypass blocked vessels. They are important signaling proteins involved in 
both vasculogenesis (the de novo formation of the embryonic circulatory 
system) and angiogenesis (the growth of blood vessels from pre-existing 
vasculature). 
 
7.12.1 In vitro angiogenesis assay: Matrigel 
 
Matrigel, a solid gel of basement proteins containing laminin, collagen type 
IV, various growth factors and proteolytic enzymes, was prepared 
according to the manufacturer‟s instructions. Briefly, 50µl of gel matrix 
solution were applied into one well of a 96-well plate and incubated for 30 
minutes at 37°C to allow the Matrigel solution to solidify. H-MSCs were 
trypsinized and 5x10
3
  were suspended in 50 µl of DMEM containing  or 
not containing VEGF, plated onto the gel matrix and incubated at 37°C 5% 
CO2.  Human umbilical vein endothelial cells (HUVEC) were used as a 
positive control. The formation of capillary-like structures was observed in 
a CKX41 Olympus (Tokyo, http://www.olympus-global.com) inverted 
microscope after 2, 4, 6, and 20 hours. Experiments were performed in 
triplicate.  
 
7.12.2 Flow cytometry assay 
 
In parallel experiments, the H-MSCs induced and control were analyzed at 
flow cytometry for the expression of endothelial antigens using the 
following anti-human moAbs:  KDR-APC (R&D Systems), FLT-1 and 
vWF (DakoCytomation) and VEGF (Abcam) to detect the surface 
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expression of VEGF receptor 2 and the cytoplasmic expression of vWF. To 
demonstrate whether VEGF could prompt MSCs to differentiate into 
endothelium, cells were permeabilized with the IntraPrep Kit (Beckman 
Coulter) and subsequently incubated with vWF MoAb for 1 hour at rt. 
After two washes with PBS, cells were incubated with FITC anti-mouse 
IgG (Beckman Coulter) for 30 minutes at rt. Samples were then washed 
twice over and incubated for 20 minutes with normal mouse Ig (Sigma) to 
saturate free anti-mouse IgG sites. Analyses were performed as described 
above (see paragraph 7.6). 
 
7.12.3 Immunofluorescence staining 
 
The expression of endothelial antigens like vWF, VEGF and KDR and was 
visualize with immunofluorescence staining. The cells, conditioned as 
described above, were seeded (5,000 cells per cm2) on slide chamber, fixed 
and permeabilized in 2% paraformaldehyde in PBS and 0,1%Tryton X-100. 
After fixation, samples were stained with a moAb against KDR (1:500, 
Sigma) and polyclonal antibodies (pAbs) vWF (1:2000; Dako Cytomation) 
and VEGF (1:50, Abcam, Cambridge). Blocking, mounting, nucleus 
counterstaining and observations were performed as described above. For 
quantitative immunofluorescence analysis, digitalized images were 
acquired at 20 and 40x magnification (final magnification 200X-400X).  
 
7.12.4 Ultrastructural analysis: TEM  
 
The subcellular features of endothelium differentiation were evaluated with 
TEM. The undifferentiated and differentiate H-MSCs, cultivated in 
presence or in absence of VEGF for up to 7 days,  were detached with 
treatment by 0.25% trypsin-EDTA, pelleted, fixed  and subsequently 
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processed for ultrastructural analysis using the procedure as previously 
described (see paragraph 7.1.4). 
 
7.13 ADIPOGENIC DIFFERENTATION 
 
Adipogenesis was induced by plating homograft cells at a density of 2x10
4
 
cells/cm
2
 in a six-well plate and cultured until semi-confluence in basal 
medium. After 24 hours, the medium was then changed to DMEM 
supplemented with 10% FBS, 0.5 mmol/L isobutyl-methyl xanthine 
(IBMX), 200 µmol/L indomethacin, 1µmol/L dexamethasone and 20 
µg/mL insulin (adipogenic induction medium; all reagents were from 
Sigma). Induction Medium was replaced every 2-3 days and alternated with 
maintenance medium (DMEM 10 % FBS and 20 µg/mL insulin). Three 
complete cycles of induction/maintenance medium stimulated adipogenic 
differentiation, forming adipocytes.  Control cells were assayed in the same 
manner, but DMEM plus 10% FBS was used instead of adipogenic 
induction/maintenance medium. 
After for 3 weeks, morphological features of adipogenic differentiation 
were observed by inverted LM and TEM, whilst the cytoplasmic presence 
of lipid droplets was assessed by Oil Red O staining. 
 
7.13.1 Oil Red O staining 
 
After the three weeks of complete rotations of culture with 
induction/maintenance adipogenic medium, oil red O staining was 
performed. This protocol revels the cytoplasmatic presence of lipid 
droplets. Each well of vascular cells was fixed in 10% neutral buffered 
formalin, gently rinsed in 60% isopropanol for 5 minutes, and incubated for 
30 minutes at rt with Oil Red O working solution to each wells. Cells 
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washed in 60% isopropanol again, lightly stained with Mayer‟s 
hematoxylin, rinsed with distilled water, mounted in aqueous mounting 
medium and viewed on phase contrast microscope. 
 
7.13.2 Ultrastructural analysis: TEM 
 
The H-MSCs were examinated for the presence of adipocytes by 
ultrastructural analysis. The cells washed with phosphate-buffered 0,15 
mol/L and fixed in 2.5% buffered glutaraldehyde directly in culture plate 
for 10 minutes at rt. After scarper, the recovered cells were collected in an 
eppendorf tube, centrifugated for 10 minutes at 1800 rpm). The pellets 
were fixed again for 24 hours at 4°C and processed for ultrastructural 
analysis using the procedure as previously described (see paragraph 7.1.4). 
 
 
7.14 OSTEOGENIC DIFFERENTATION 
 
For osteogenic differentation, a 70% subconfluent culture of H-MSCs from 
P4 was used. 5x10
3
 cells/cm
2
 were plated in six well and one day after 
plating, the medium was replaced with fresh osteogenic induction medium 
DMEM supplemented with 15% FBS, 10 mmol/L β-glycerophosphate, 
0.17 µmol/L ascorbic acid, and 0,1µmol/L dexamethasone (all Sigma) and 
cultured for 3-4 weeks replacing the medium every 2-3 days. Controls were 
cultured in basal medium (DMEM with 10% FBS). All experiment was 
followed by the morphological evaluation by phase contrast microscope. 
To demonstrate osteogenesis, the cells cultured were fixed and assessed by 
Von Kossa staining and TEM to identify calcium salt extracellular 
deposition. 
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7.14.1 von Kossa staining 
 
Deposits of calcium or calcium salt were detected by von Kossa staining. 
This technique is not specific for the calcium ion itself. In this method, 
tissue sections are treated with a silver nitrate solution and the silver is 
deposited by replacing the calcium reduced by the strong light, and thereby 
visualized as metallic silver. 
After removing the correspondent media from the wells, the cells plated 
were gently rinsed with PBS and fixed in 10% neutral buffered formalin. 
After that, cells were rinsed in distilled water and incubated in 1% silver 
nitrate solution under UV for 20 minutes at rt. Subsequently, several 
changes of distilled water are very important to wash silver nitrate out 
completely to prevent false positive. Samples were stained with a solution 
of 5% sodium thiosulfate to remove unreact silver for 5 minutes at rt, 
washed in distilled water, counterstained with 1% nuclear fast red solution, 
dehydrated trough graded alcohol and mounted  using a permanent 
mounting medium (Canadian Balsam, Sigma). 
 
7.14.2 Ultrastructural analysis: TEM 
 
The calcium deposition in H-MSCs, after the osteogenic induction, was 
also analysed by ultrastructural analysis. The cells washed with phosphate-
buffered 0,15 mol/L and fixed in 2.5% buffered glutaraldehyde directly in 
culture plate for 10 minutes at rt. After scarper, the recovered cells were 
collected in an eppendorf tube, centrifugated and pellets were fixed again 
for 24 hours at 4°C and after processed for ultrastructural analysis using the 
procedure as previously described (see paragraph 7.1.4). 
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7.15 CHONDROGENIC DIFFERENTATION  
 
To induce chondrogenic differentiation, aliquots of 2,5x10
5
 cells were 
collected, centrifugated and gently pelleted in 15 ml polypropylene conical 
tubes (Corning) in 0,5 ml of DMEM medium. After 24 hours, the basal 
medium was then changed to chondrogenic differentiation medium (Lonza) 
containing DMEM, 2,5 µl dexamethasone, 5 µl ascorbate, 5 µl ITS+ 
supplement, 5 µl sodium pyruvate, 5 µl proline, 0,5 µl 
Gentamicin/Ampicillin 1000, 10 µl L-Glutamine supplemented with 10 
ng/ml TGFβ3 (all product were from Lonza). Loosen the caps of the tubes 
containing pellets one half turn to allow the gas exchange and incubated at 
37°C in humified atmosphere 5% CO2 and cultured for three weeks in 
complete by feeding the cell pellets twice a week by completely replacing 
the medium taking care not to distrupt the pellets. Controls were cultured in 
chondrogenic differentiation medium without TGFβ3. To verify H-MSCs‟ 
chondrogenic differentiation potential, pellets were fixed and processed for 
histological and immunohistochemical staining and TEM analysis to 
evaluate proteoglycans and collagen type 2 synthesis.  
 
7.15.1 Alcian Blue staining 
 
To establish the extracellular release of sulfated proteoglycans, a 
component of chondrogenic extracellular matrix, Alcian Blue staining was 
performed. Varying the PH of the solution of Alcian Blue more 
information can be gained concerning the types of acid mucin present. 
After the induction period, pellets were formalin-fixed and paraffin 
embedded. The dewaxed sections were stained with 1% Alcian blue in 3% 
glacial acetic acid at pH 2.5 for 30 minutes at rt; after rinsing in distilled 
water, hematoxylin counterstaining, the sections were dehydrated, mounted 
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with permanent mounting medium (Canadian Balsam, Sigma) and  viewed 
on LM. 
 
7.15.2 Type II collagen: immunohistochemical analysis 
 
To assess chondrogenic potential, immunohistochemical staining was 
performed with an anti-human collagen type II (Chemicon International, 
Millipore, Billerica, MA) and a non-biotin-amplified method (NovoLink
TM
 
Polymer Detection System, Novocastra Laboratories Ltd., Newcastle Upon 
Tyne, United Kingdom) to evaluate the expression of type II collagen, a 
specific markers of chondroblasts. Briefly, pellets were formalin-fixed and 
embedded in paraffin to obtain 3µm-thick sections. H&E staining was used 
for histological assessment. Additional dewaxed sections were digested 
with pepsin (0.5 mg/ml Tris-HCl, pH 2.0) for 15 minutes at rt; endogenous 
peroxidase activity was blocked using absolute methanol containing 1.5% 
H2O2. Sections were incubated with mouse moAb anti-human collagen type 
II (1:200, Chemicon Int) in 1% BSA-PBS in a wet chamber at 4°C o.n. The 
antigen-antibody reaction was revealed using the Novolink Polymer 
detection System according to the manufacturer‟s protocol. The signal was 
developed with diaminobenzidine cromogen and sections were 
counterstained with Gill‟s hematoxylin. Subsequently, the samples were 
dehydrated, coverslipped and viewed in a LM using the Image-Pro Plus
®
 
program. Negative control was obtained by omitting the primary moAb. 
 
7.15.3 Ultrastructural analysis: TEM 
 
The H-MSCs pellets were examinated by ultrastructural analysis for to 
detect the presence of collagen fibers and extracellular matrix containing 
proteoglycans. The cells was washed, fixed in 2.5% buffered 
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glutaraldehyde for 24 hours at 4°C and processed for ultrastructural 
analysis using the procedure as previously described (see paragraph 7.1.4). 
 
 
7.16 LEIOMYOGENIC DIFFERENTATION 
 
To induce leiomyogenic induction, 2x10
3
 H-MSCs at P5 were seeded in a 
six-well plates (Corning) in Smooth muscle Growth Medium (SmGM-2; 
Lonza). The next day, the medium was replaced with induction medium 
containing SmGM-2 plus 10 ng/ml TGF-β1 (Sigma) and 5 ng/ml PDGF-
BB (Sigma).  
TGF-β1 is a multipotent cytokine that is involved in the regulation of 
angiogenesis (Pepper, 1997); has a protective role like control of vascular 
cell proliferation, maintenance of differentiation and increase its 
immunomodulatory and anti-inflammatory effect (Mallat et al., 2002). 
PDGF-BB is a potent mitogen for a wide range of cell types including 
fibroblast, smooth muscle and connective tissue; growth factors that 
regulate cell growth and division and are involved in leiomyogenic 
differentiation. 
The medium was changed every 3 days and the induction period lasted for 
2 weeks. Cell controls were assayed in the same manner using SmGM-2 
without additional growth factors. To evaluate smooth muscle marker 
expression, immunofluorescence, RT-PCR and TEM analysis were 
performed. 
 
7.16.1 Immunofluorescence analysis 
 
To investigate whether the H-MSCs are able to differentiate into 
leiomyogenic lineages, evaluating the expression of smooth muscle specific 
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antigens, an immunofluorescence staining was used. H-MSCs were washed 
with PBS, fixed and permeabilized with 2% paraformaldehyde 0,1% 
Tryton X-100 in PBS for 4 minutes at rt. Background staining was blocked 
by incubating  with blocking solution containing goat serum (1:10, Sigma-
Aldrich) in 1% BSA in PBS  for 30 minutes at rt in a wet chamber. Cells 
were incubated for 45 minutes at 37°C in a wet chamber with the following 
anti human mouse moAbs: α-SMA( 1:9000, clone 1A4); H-Caldesmon 
(clone h-CD, 1:75); Calponin (clone CALP, 1: 40); Vimentin (1: 260, clone 
V9) all taken from Dako Cytomation). Antigen-antibody reactions were 
labeled with goat anti-mouse Alexa Fluor
®
 488 (1:250, Invitrogen 
Corporation, Camarillo, CA) in 1% BSA in PBS for 1 hour at 37°C. After 
several washes, samples were mounted and nuclei counterstained with “Pro 
long antifade reagent with DAPI” (Molecular Probes). Negative controls 
were done by omitting the primary antibodies. 
 
7.16.2 Semiquantitative analysis: RT-PCR 
 
The expression of smooth muscle specific genes, such as α-SMA, calponin 
2 and caldesmon, was evaluated by RT-PCR. Total RNA was extracted 
from induced and non induced cells and RT was performed as described 
above. The primers listed in table below (Table2) were selected for 
amplification using GoTaq Hot Start Polymerase (Promega Corporation, 
USA); for detection of β2-µglobulin, ASMA, Calponin, and Caldesmon, 
the following parameters were used: 94°C for 3 minutes and then 30 cycles 
of 40 seconds at 94°C for denaturation, 30 seconds at 60°C for annealing, 
90 seconds at 72°C for polymerization, and 5 minutes at 72°C. The PCR 
products were separated by electrophoresis on a 1.5% agarose gel with 1x 
Tris-acetate-EDTA buffer, stained with ethidium bromide and 
photographed under UV. 
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Table2: PCR primers sequence, annealing temperature and amplicon 
length for each gene used to quantify the smooth muscle gene expression  
 
 
7.16.3 Ultrastructural analysis: TEM 
 
TEM analysis of H-MSCs leiomyogenic differentiation was performed as 
described above. The cells washed with phosphate-buffered 0,15 mol/L and 
fixed in 2.5% buffered glutaraldehyde directly in culture plate for 10 
minutes at rt. After scarper, the recovered cells were collected in an 
eppendorf tube, centrifugated for 10 min at 1800 rpm). The pellets were 
fixed again for 24 hours at 4°C and processed for ultrastructural analysis 
using the same procedure as previously described (see paragraph 7.1.4). 
 
 
 
 
 
 
 
GENE Primers Sequence Amplicon  
lenghth (bp) 
Ta°C 
ASMA REV 5‟- GTGATCTCCTTCTGCATTCGGT-3‟ 
FW 5‟- CTGAGCGTGGCTATTCCTTC-3‟ 
372 60 
CALP2 REV 5‟-GCAGGTCTGAGGGTCTGAAG-3‟ 
FW 5‟-CCAGTCAACCAAGGGTCTGT-3‟ 
470 60 
CALD REV 5- GCTGCTTGATGGGTCGATTTGA-3‟ 
FW 5‟- GTCACCAAGTCCTACCAGAAGA-3‟ 
Low: 744 
High: 1508 
60 
 
β2-
µglobulin 
REV 5‟-ATCTTCAAACCTCCATGATG-3‟ 
FW 5‟-ACCCCCACTGAAAAAGATGA-3‟ 
114 58 
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8. RESULTS 
 
8.1  ORGAN CULTURE 
To furnish a direct prove of  VW-MSCs  involvement in vascular 
remodeling, repair and in stress conditions, we optimize a new useful 
approach consisting in a long-term organ culture system, up to 70 days, 
which gives us the opportunity to learn the spontaneous vascular wall 
remodeling in a three-dimensional system whitout the influence of 
circulating blood components. The experiment was performed on healthy 
adult human femoral artery segment.  
 
8.1.1  Organ culture histological analysis  
 
The histological analysis performed on H&E stained sections was used to 
verify the overall response of arterial wall resident cells to culture 
conditions; particular attention was paid on evaluating the number of cells 
within each arterial layers and their contribution to parietal remodeling 
during organ culture. Samples seen at day 0 showed an architecture and 
cellularity comparable to that of normal arterial samples before culture and 
consequently were considered as control. Within each arterial layer, cells 
showed normal cytological details; endothelial and smooth muscle cells 
were easily recognizable; the adventitia layer contained a rich vascular 
plexus. Minimal cell changes were observed up 35 days of organ culture. 
At day 14 cells decreased in the intima whereas no significant difference 
was seen in the medial and adventitial layers. At day 21 the number of 
intimal cells increased and the media showed a consistent cell decrease; in 
the adventitia cellularity remained unchanged. Between 28 and 35 days 
there was an overall decrease in arterial wall cellularity and only a few 
spindle cells were seen in intima and media layers; adventitia contained no 
Experimental Design - Results 
- 76 - 
 
cell at all. At 42
 
days the external surface of the adventitia and intima 
tunica were lined with a single layer of spindle cells, while media did not 
show significant changes (Fig.23).  
 
Fig.23: Histological analysis of organ 
culture. a) Organ culture time 0. b) 
Remodeling of intima tunica after 42 
days of organ culture. c) Remodeling of 
adventitial tunica after 42 days of organ 
culture 
 
 
 
 
 
 
 
 
 
 
 
 
 
At day 49 cell linings became more continuous and the adventitial 
thickness increased due to cell multilayering; these spindle cells also 
showed a tendency to migrate toward the external edge of the samples; on 
the contrary the inner portions of intima and media did not contain cells. 
These features remained unchanged from day 56 up to the end of the organ 
culture. Results are schematized in the figure below (Fig.24). 
 
 
a 
b 
c 
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Fig.24: Schematic representation of organ culture vascular wall remodeling  
 
8.1.2  Immunohistochemical analysis 
 
The immunohistochemical analysis was performed to investigate cell 
immunophenotype changes during organ culture remodeling. Basically a 
panel of moAbs and pAbs against molecules expressed by MSC (CD105, 
CD90 and CD44), endothelial cells (CD34, CD31 and VWF), smooth 
muscle cells (ASMA, Vimentin and Desmin), stem cells (c-kit, Stro-1) and 
mast cells (Tryptase) was used.  
The cell immunophenotype of samples taken at day 0 was quite similar to 
that of normal femoral artery including the presence of small caliber 
CD34
+
/CD31
- 
vessels between the media and adventitia layers.  
The most interesting results are those related to the observations carried out 
from 42 days of organ culture; in fact, spindle cells lining the adventitia 
surface showed a mesenchymal phenotype, i.e., CD44
+
, CD90
low
, 
CD105
low
, Vimentin
+
. On the contrary, spindle cells covering the intima 
expressed almost exclusively the endothelial cell molecule CD31
+ 
and a 
focal presence of CD34 expressing cells that did not exceed the 20% of the 
intimal lining cells; except for Vimentin all other investigated proteins 
were negative, including CD44, CD34, α-SMA, Desmin, CD90, CD105 
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and Tryptase). Tha vascular wall was intensly positive for Vimentin, α-
SMA and Desmin. 
To study the presence of uncommitted stem cells residents in the vascular 
wall of human femoral artery, further investigations were carried out using 
specific stem cell markers such as Stro-1 and c-Kit; while the bone-marrow 
stromal cells marker, Stro-1, was consistently negative scattered c-Kit 
positive cells were seen in the adventitia; these cells had a spindle 
morphology with long and elaborated cytoplasmic projections (Fig.25); in 
contiguous sections, Tryptase
+
 cells was also found; these cells were 
located between media and adventitia layers and in the external edge, with 
a distribution pattern that was not superimposable with that of c-Kit 
expressing cells (data not show). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.25: Immunohistochemical analysis of typical CD markers present on 
MSCs (CD90, CD44, CD105), endothelial markers (CD31, CD34), smooth 
muscle markers (ASMA, VIMENTIN, DESMIN) and stem cell markers (c-
Kit, Stro-1)  Magnificatio 10X-20X 
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8.1.3  Ultrastructural analysis: TEM 
 
TEM observation showed that adventitia presents a heterogeneous 
population: cells directed toward the endothelial phenotype, myoid cells 
and mesenchymal stromal cells. Endothelial cells were characterized by 
intermediate filaments with a lassa distribution of vimentin, micropinocitic 
vesicles and tight junctions; in the cytoplasm there were also oval 
electrodense granules; probably immature bodies of Weibel-Palade 
(Fig.26). Moreover, spindle cells with typical ultrastructural characteristics 
of smooth muscle cells: abundant contractile actin filaments, solitary sub-
plasmalemmal densities and basal lamina (Fig.27). At the end, we observed 
then cells with a high nucleus/cytoplasm rate with a large euchromatic 
nuclei and prominent nucleoli. In the cytoplasm, the rER cisternae were 
distended, some mitochondria and free glycogen were found (Fig.28). 
These last features are coherent with those described for mesenchymal 
stromal cells in bone marrow. 
 
Fig.26: Ultrastuctural features 
of endothelial phenotype into 
adventitial tunica.Abbreviation: 
N: nuclei, W-E: Webel Palade 
boby  
 
 
 
 
 
 
 
 
 
N 
W-P 
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Fig.27: Ultrastuctural features 
of mesenchymal stem 
phenotype into adventitial 
tunica. Abbreviation: N: nuclei, 
Nu: nucleoli 
 
 
 
 
 
 
 
 
 
 
Fig.28: Ultrastuctural features 
of smooth muscle phenotype 
into adventitial tunica. 
Abbreviation: m: mitochondria, 
FA: actin filament 
                                                                               
 
 
                                                                
 
 
 
            
 
 
 
 
 
 
 
Nu 
N 
FA 
m 
N 
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8.2 HISTOLOGICAL ANALYSIS OF HUMAN VASCULAR WALL 
HOMOGRAFT 
 
The hematoxylin and eosin staining, performed on human vascular wall 
homografts, was used for histopathological assessment. With the optic 
microscope both posterior left femoral-tibial homograft rings appeared with 
a compromised case history. In both segments were found an aneurysmal 
dilation mainly in the medial tunica, causing its thinner and its fibrosis. 
Moreover, the sample show a 2°grade arteriosclerosis with an associated 
lipid core(Fig.29d); the observation showed also focus of adventitial 
angiogenesis with an associated chronic inflammation(Fig.29b). 
The lumen of the arterial segment appeared obstructed by an overlying 
parietal thrombosis (Fig. 29a)  richly vascularized(Fig.29c). 
Finally were observed signs of a preexisting parietal haemorrhage rich in 
monocytes macrophages containing haemosiderinic elements especially in 
the border line between the medial and adventitial tunicas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a b 
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Fig.29: Histological analysis of vascular wall homograft. a) overlying 
parietal thrombosis. b) chronic inflammation. c) thrombo richly 
vascularized. d) lipidic core 
 
 
8.3  VASCULOGENIC ZONE” IN SITU: 
IMMUNOHISTOCHEMICAL ANALYSIS 
 
The immunohistochemical analysis was performed, on each vascular wall 
homograft, to identify and to localize the adult stem cell populations that 
could be reside in the vasculogenic zone using specific antibodies 
commonly expressed by mesenchymal stem cells like: 
 
 CD44: is a receptor for hyaluronic acid and it is involved in adhesion 
between hyaluronate and other proteoglicans in the extracellular 
matrix including collagen and fibronectin. 
 
 CD105: also known as endoglin. This antibody is present on 
endothelial cells, erythroblasts, monocytes, and connective tissue 
stromal cells and facilitates enrichment of stromal progenitors from 
bone marrow. 
 
c d 
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 CD90 or Thy1: cell surface protein that can be used as a marker for 
a variety of stem cells.  
 
 CD166 or ALCAM (activated leukocyte adhesion molecule): a 
transmembrane glycoprotein involved in the osteogenic 
differentiation and also is expressed on lymphocyte B, T and 
macrophages. 
 
 
The immunohistochemical analysis showed numerous cells highly positive 
for CD44 and some other cells weakly positive for CD90 localized mainly 
in the vasculogenic zone corresponding to the border line between medial 
and adventitial tunicas of the homograft wall. Besides, even pericytal and 
perivascular cells of the rich vascular plexus present in the adventitial 
tunica showed an high positivity for CD44 and a low positivity for CD90. 
Near the vasculogenic zone were also observed sporadic cell weakly 
positive for  CD105
low
 and CD166
low 
(Fig.30). 
Those observation confirmed the existence of a vasculogenic zone  in the 
border line between the medial and adventitial tunicas in the vascular wall, 
in which resides a population of stem cell potentially able to generate, in a 
specific hierarchic organization, stromal  supporting elements (MSC). 
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Fig.30: “Vasculogenic zone” in situ immunohistochemical analysis 
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8.4  ISOLATION AND CELL CULTURE 
 
From 25-30cm
2
 of each sample of vascular wall homograft we succeeded 
in isolating mononuclear cells using a combination of enzymatic and 
mechanical procedures, as previously described in materials and methods 
section. The initial number of primary cell cultures varied from 1,5x10
6
 to 
3,5x10
6
.  Cells isolation was carried out successfully in only one case. The 
remaining cases were discarded due of a fast growth of contaminant 
bacteria at passage 2 to avoid delivering erroneous experimental results. 
After approximately 2-3days from initial seeding, the observation to phase 
contrast microscopy from cells in P0 demonstrated a strong adherence to 
plastic and fibroblast-like spindle-shape morphology and had a tendency to 
grow in colonies, estimating 36 hours as doubling time. During the cell 
culture, this spindle-shape cells were highly proliferating increasingly 
assuming the morphological properties of MSCs from bone marrow 
(Fig.31).  
 
 
Fig.31: MSCs isolated from vascular wall homograft. a) The cell morphology 
after 3 days of culture, bar =20 μm; b) Typical phenotype of mesenchymal 
stromal cells after P3 in culture (Magnification 10X) 
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The final number of resident mesenchymal stem cells isolated from 25 cm
2
 
of homograft segment was estimated around ≈ 0,5-2,0x104 cells, thus 
demonstrating that MSCs population is present in homograft. The cells 
were cultured in collagen type I flasks in DMEM supplemented 10%FBS 
for up to P10-P12 for expansion without losing the proliferative capacity, 
like the culture of BM-MSCs.  
 
 
8.5  IMMUNOPHENOTYPING: FLOW CYTOMETRY ANALYSIS 
 
The cells isolated from vascular wall homograft were subsequently 
analyzed for the single expression of characteristic markers generally used 
to identify the MSCs and stem cells using a flow cytometric analysis.  
The fibroblast-like cells culture taken at P3 were evaluated at their surface 
with a panel of antigens found in MSCs (CD90, CD44, CD105, CD29, 
CD73); hematopoietic lineage (CD45), hematopoietic progenitor (CD117, 
CD34, CD133), endothelial cells (CD31, vWF, CD146, KDR) and 
stemness markers (c-Kit, Notch-1, Oct-4, Sca-1, Stro-1) and perycite cells 
(NG2). As other mesenchymal stem cells, the majority of H-MSCs 
expressed typical mesenchymal antigens such as CD90, CD44, CD105, 
CD29, CD73 and NG2. On the contrary, they were negative for the early 
and mature hematopoietic markers CD34 and CD133 and for mature 
hematopoietic markers CD45. H-MSCs were also negative for KDR, 
CD146, CD31 and vWF which are markers of differentiated endothelium 
whilst c-Kit was not detected (Fig.32). 
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Fig.32: Flow cytometry analysis of typical CD markers present on MSCs 
and Pericytes and typical hematopoietic and endothelial markers which are 
not expressed by MSCs  
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The cells intensely expressed stemness markers such as Oct-4 and Notch-1; 
Sca-1and Stro-1 were also expressed although at lower level (Fig. 33). 
 
Fig.33: Immunophenotype of stemness markers expressed by H-MSCs in 
flow cytometry analysis.  
 
 
In conclusion, the phenotype of H-MSCs isolated was CD44
+
, CD90
+
, 
CD105
+
, CD29
+
, CD73
+
, Sca-1
low
, Stro-1
+
, Oct4
+
, Notch-1
+
, CD45
-
, CD34
-
, 
CD133
-
, KDR
-
, CD31
-
, vWF
-
, CD146
-
, c-Kit
-
 and NG2
+
. 
 
 
8.6  IMMUNOFLUORESCENCE ANALYSIS 
 
In addition to flow cytometry analysis, a single immunofluorescence 
staining was performed to investigate the smooth muscle phenotype of H-
MSCs isolated. The cells, taken at the same passage used in flow cytometry 
analysis, were stained with intracytoplasmatic antigens against to smooth 
muscle markers (α-SMA, Calponin, h-Caldesmon, Vimentin, Desmin, and 
PDGF-rβ) and Ki-67 a proliferation‟s marker. The fibroblast-like cells 
showed a mesenchymal phenotype resulted positive for Vimentin and 
Calponin while, surprisingly, we observed rare cells positive for the α-
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SMA staining and the absence of other smooth muscle markers like h-
Caldesmon, Desmin and PDGF-rβ (Fig.34). 
Fig.34: Immunofluorescence characterization of H-MSCs cultured on slide 
chambers. Cells were stained with moAbs directed against to smooth 
muscle markers. Negative control (A), α-SMA (B), Vimentin (C) and 
Calponin (D). Nuclei in blue and cell positive in green 
 
 
8.7  ULTRATRSTUCTURAL ANALYSIS: TRANSMISSION 
ELECTRON MICROSCOPY (TEM) 
 
At P4, the subcellular characteristics of these cells derived from vascular 
wall homograft were investigated by transmission electron microscopy 
(TEM). The observation revealed cells with a high ratio nucleus/cytoplasm 
with a large euchromatic nuclei and prominent nucleoli. The abundant 
A B 
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cytoplasm containing numerous organelles, e.g., some mitochondria, a few 
lipid droplets, the rough endoplasmic reticulum (rER) with cisternae 
dilated, free glycogen. More careful observation of peripheral cytoplasm 
shows the presence of collections of clear vesicles, vacuoles and blisters 
giving a labyrinthine appearance (Fig.35). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.35: Ultrastructural features of H-MSCs. a) High ratio nucleus 
(N)/cytoplasm b) Abundant cytoplasm containing the rough endoplasmic 
reticulum (rER) with cisternae dilated and free glycogen c) peripheral 
cytoplasmic collections of clear vesicles, vacuoles and blisters Scale bar=2 
μm.  
 
a b 
c 
rER 
N 
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All these ultrastructural features are coherent/accord with those described 
for mesenchymal stromal cells isolated from bone marrow as already 
reported in our previous study (Pasquinelli et al. 2007, b).  
 
 
8.8  STEM CELL GENES EXPRESSION ANALYSIS: RT-PCR 
 
The gene expression performed on H-MSCs was evaluated by RT-PCR. 
This semiquantitative analysis confirmed stem cell gene expression 
showing that these cells constitutively expressed transcripts associated with  
embryonic stem cell marker, Oct4, and some molecules involved in stem 
cell critical regulatory pathways i.e., Notch-1, BCRP1, as well as, to a 
lower extent, hematopoietic stem cell transcripts such as KDR and CD133.  
The RT-PCR analysis demonstrated that these cells at P4 expressed 
BCRP1, that maintained the undifferentiated state of embryonic stem cells; 
Notch-1, that regulated the stemness and the undifferentiated status of H-
MSCS; and lower expression level of Oct4 governing pluripotency and cell 
fate determination of embryonic stem cells (Pan et al., 2002). Moreover, 
the H-MSCs showed very low expression of KDR, receptor type 2 of 
VEGF, as well as CD133, hematopoietic stem cell transcripts. (Fig.36). 
The positive control, BM-MSCs, expressed all the molecules involved in 
stem cells conditions, like CD133, Oct-4, BCRP-1, BMI-1 while they 
didn‟t expressed the hematopoietic stem cells molecules c-Kit and KDR 
(Pasquinelli et al., 2007 b). 
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Fig.36: Stem cell genes expression analysis by RT-PCR performed on cells 
isolated from arterial homograft. On the left, the lane shows transcript 
expression found in H-MSCs. On the right, the lane indicates the genes 
expression by BM-MSCs. β2μ was used as a house-keeping gene.  
 
 
 
8.9  PROLIFERATION ASSAY: ALAMAR BLUE 
 
The kinetics of cell proliferation was evaluated directly “in vivo” for up 21 
days using Alamar Blue™ assay a non-toxic aqueous dye which is reduced 
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a b 
by all components of the mitochondrial respiratory chain and highlights the 
cells metabolically active (intact and functional mitochondria). The results 
of assay highlight that proliferative capacity of  these cells increases with 
time,  reaching a plateau on day 10 and then remain almost constant until 
day 21 (end of the experiment) (Fig.37a). 
The marked cell proliferation of cells under study was confirmed also by 
positive immunofluorescence for Ki-67. Ki-67 is a cell proliferation marker 
able to recognize a nuclear and nucleolar  protein expressed in the G1, S, M 
and G2 phases of the cell cycle. This data suggested that H-MSCs have 
high-growth potential (Fig.37b). 
 
 
Fig.37: Evaluation of cell proliferation of H-MSCs. a) By Alamar Blue 
fluorescence assay. Values are given as means of fluorescence of a single 
experiment in triplicate. b)  Ki-67 immunofluorescence staining confirmed 
the high proliferation of H-MSCs. Nuclei in blue and nuclear/nucleolar 
positivity in green. 
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8.10  ANGIOGENIC DIFFERENTIATION 
 
The angiogenic capacity of MSCs isolated from vascular wall homograft, 
induced for 7 days with 50 ng/ml VEGF to form capillary-like structures, 
was performed according to Oswald (Oswald et al., 2004). The features of 
angiogenic differentiation were evaluated using the in vitro angiogenesis 
assay and confirmed by various technique. 
 
8.10.1 In vitro angiogenesis assay: Matrigel 
 
The ability to form capillary-like tube formation was tested in a semisolid 
matrix with an in vitro angiogenesis kit. Cells, taken at P4, were cultured 
until near confluence for 7 days in absence or presence of VEGF and 
observed at regular intervals during the following 24 hours. 
Undifferentiated and differentiated H-MSCs were trypsinized and seeded 
on the top of the ECMatrix or Matrigel gel solution. After 2 hours, the 
undifferentiated H-MSCs organized themselves in a few capillary 
structures and most of the cells remained scattered in the medium. When 
cultivated in the presence of VEGF, the cells rapidly aligned themselves 
and formed hollow tube-like structures with thin cytoplasmic projections 
sprouting from the cell periphery. After 4 hours, the same cells appeared 
connected by thicker projections forming an evident capillary-like network 
but after only 6 hours this capacity was lost.  
On the contrary, HUVEC, used as positive control, spontaneously 
aggregated in a capillary-like network when seeded on Matrigel (Fig.38). 
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Fig.38: Light microscopy analysis of differentiated and undifferentiated H-
MSCs on semisolid matrix in presence and absence of VEGF. A) HUVEC 
as positive control; B) Undifferentiated H-MSCs; C) After to 2 hours from 
Matrigel seeding; D) After  4 hours from Matrigel seeding  
 
 
8.10.2 Flow cytometry assay 
 
After 7 days, the cells cultured in a conditioned medium with or without 
VEGF were evaluated with an indirect immunofluorescence flow 
cytometry to quantify the endothelial-specific marker expression. 
Differentiated H-MSCs showed a completely absence of expression of the 
VEGF receptor-II or KDR and a lower expression of the VEGF receptor-I 
or FLT-I. Moreover, a single labeling experiment demonstrated the VEGF 
promoted the vWF cytoplasmatic expression (marker of mature 
endothelium) and the synthesis of VEGF (Fig.39).   
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Fig.39: Flow cytometry analysis for the expression of endothelial-specific 
markers after angiogenic differentiation of H-MSCs  
 
 
8.10.3 Immunofluorescence staining 
 
The immunofluorescence staining, performed on undifferentiated and 
differentiated cells to quantify the endothelial-specific molecules, 
confirmed the data obtained in flow cytometry (data not show). 
 
8.10.4 Ultrastructural analysis: TEM 
 
The subcellular characteristics of undifferentiated and differentiated H-
MSCs, after 7 days of angiogenic differentiation, were evaluated with 
transmission electron microscopy. The observation on H-MSCs pellet, 
when cells had been treated with VEGF, not showed features consistent 
with an early endothelial phenotype such as electron-dense oval-shaped 
granules possibly representing immature Weibel-Palade bodies (data not 
show). 
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8.11 ADIPOGENIC DIFFERENTIATION 
 
After the three complete rotations of cell culture with adipogenic induction 
medium and adipogenic maintenance medium, oil Red O and 
ultrastructural analysis was performed.  
 
8.11.1 oil Red O staining 
 
H-MSCs treated with adipogenic media showed the presence of multiple 
lipid-rich vacuoles into cytoplasm that increased in size and number with 
the time of induction (Fig.40).  
          NON INDUCTION 10DAYS                   INDUCTION 10 DAYS   
           
           NON INDUCTION 20DAYS                 INDUCTION 20 DAYS    
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Fig.40: During the adipogenic differentiation, fresh specimens, observed at 
light microscopy after 10 days and 20 days of induction, showed the 
presence of multiple lipid-rich vacuoles (Magnification 20X) 
 
Controls, by contrast, retained their morphology and did not display 
significant cytoplasm vacuoles.  
 
Vacuoles within cells were stained with the lipid dye Oil Red O (Fig.41).  
Fig.41: Adipogenic differentiation of H-MSCs shown by positive staining 
for neutral lipid vacuoles (red) demonstrated by the Oil Red O reaction 
(Magnification 10X) 
 
 
8.11.2 Ultrastructural analysis: TEM 
 
Ultrastructural observation showed that H-MSCs contained multiple, 
confluent lipid droplets in the cytoplasm and small dense mitochondria, 
besides an elevated endocytic activity (Fig.42).  
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Fig.42: Ultrastructural features of 
adipocytes derived from vascular 
wall homograft. a) Cytoplasmic 
lipid vacuoles. b) Confluent lipid 
droplets. c) Undifferentiated H-
MSCs 
 
 
 
 
 
8.12 OSTEOGENIC DIFFERENTIATION 
 
The osteogenic differentiation potential, of mesenchymal stem cells 
isolated by vascular wall homograft and cultured for up to 21 days in an 
osteogenic induction medium, was evaluated in light microscopy and 
transmission electron microscopy to identify the calcium salt deposits in 
extracellular matrix. 
 
 
a b 
c 
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8.12.1 von Kossa staining 
 
 At light microscopy, the morphological changes in H-MSCs during 
osteogenic induction were first noted around 10 days after plating, when 
the differentiated cells have lost their cytoplasmic extension (Fig.42). The 
quantity of calcium deposition increased with the time of induction 
(Fig.43). 
Fig.42: Fresh specimens were observed during the experiment. The 
morphological changes of H-MSCs were noted after osteogenic induction 
around 10 days after plating (Magnification 20X) 
Fig.43: Fresh specimens were analyzed during the experiment. At light 
microscopy, the calcium deposits increased with the time of induction 
(Magnification 10X) 
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After the morphological change, marked calcium deposition was observed 
under phase contrast microscope, increased over time and it was confirmed 
by von Kossa staining. Brownish calcium deposits were spread evenly 
across the plate of induced H-MSCs and completely absent in non induced 
cells. Controls, by contrast, retained their morphology and did not display 
calcium deposition in extracellular matrix (Fig. 44). 
 
 
Fig.44: Osteogenic differentiation of H-MSCs shown by positive staining 
for calcium deposits (brownish) demonstrated by the von Kossa reaction. 
(Magnification 10X) 
 
 
 
 
8.12.2 Ultrastructural analysis: TEM 
 
The ultrastructural analysis of H-MSCs, after 3 weeks of osteogenic 
induction, revealed multiple foci of electron dense fibrillary deposits which 
were decorated with needle-shaped hydroxyapatite crystals (Fig.45). 
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Fig.45: TEM analysis of H-MSCs after osteogenic committed. a) Osteoid 
matrix. b) Needle-shaped hydroxyapatite crystals. c) Terminal 
osteogenesis. d) undifferentiated H-MSCs  
 
 
8.13 CHONDROGENIC DIFFERENTIATION 
 
The chondrogenic potential of undifferentiated and differentiated H-MSCs 
pelleted and cultured in a medium without serum and containing 
a b 
c d 
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transforming growth factor-β3, under hypoxic condition, was assessed with 
alcian blue staining, immunohistochemical and ultrastructural analysis. 
 
8.13.1 Alcian blue staining 
 
Light microscopy on high-density H-MSCs pellets revealed that the cells 
were embedded in an abundant extracellular matrix during culture.  The 
presence of a proteoglycan-rich extracellular matrix was shown by alcian 
blue staining in induced cells but not in controls (Fig.46). 
 
Fig.46: Alcian Blue staining of H-MSCs cultured as a pellet. There are 
abundant collagen bundles in the extracellular matrix of differentiated cell.  
 
 
8.13.2 Type II collagen: immunohistochemical analysis 
 
Chondrocyte-like lacunae were evident in histological sections, and 
immunohistochemistry analysis focally revealed, in extracellular matrix, 
the presence of human type II collagen, specific marker for chondroblasts, 
which is typically found in joint cartilage (Fig.47). 
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Fig.47: Immunohistochemical staining was focally positive for human type 
II collagen in extracellular matrix 
 
 
8.13.3 Ultrastructural analysis: TEM 
 
More careful ultrastructural observation confirmed the presence of 
abundant extracellular matrix containing mature collagen fibers and 
proteoglycan particles in induced cells exclusively (Fig.48). 
 
 
a b 
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Fig.48: TEM analysis of H-MSCS after chondrogenic differentiation. 
a)Collagen fibers and proteoglycan particles. b) Increased mature collagen 
fibers. c) and d) Undifferentiated H-MSCs. 
 
 
 
8.14 LEIOMYOGENIC DIFFERENTIATION 
  
TGF-β1 and PDGF-BB were added to the culture medium for 2 weeks to 
induce leiomyogenic differentiation of mesenchymal stem cells isolated 
from human vascular wall homograft and the cellular response was 
assessed by immunofluorescence and RT-PCR for smooth muscle-specific 
markers expression and verified throughout ultrastructural analysis. 
 
 
 
 
 
 
c d 
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8.14.1 Immunofluorescence analysis 
 
Immunofluorescence labeling of undifferentiated and differentiated H-
MSCs illustrated that, after culturing of 2 weeks in a medium containing 
TGF-β1 and PDGF-BB, they acquired the ability to express de novo α-
SMA and Caldesmon while caused an increase of Calponin protein in the 
cytoplasm (Fig.49). 
 
Fig.49: Immunofluorescent analysis of leiomyogenesis. Protein expression 
modulation of smooth muscle markers such as α-SMA, calponin, 
caldesmon and in differentiated and undifferentiated cells. Nuclei in blue 
and cell positive in green. 
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8.14.2 Semiquantitative analysis: RT-PCR 
 
The expression of smooth muscle specific genes, such as α-SMA, calponin 
2 and caldesmon, was evaluated by RT-PCR. Surprisingly we observed an 
upregulation of all genes and did not notice any differences between 
induced and uninduced samples (Fig.50).  
 
                                      INDUCED      UNINDUCED 
 
      ASMA 
 
 
      CALP2 
 
 
      CALD 
 
 
      β2-µglobulin 
 
 
 
 
Fig.50: RT-PCR of smooth muscle markers. Beta-2globulin was used as 
control gene. 
 
 
8.14.3 Ultrastructural analysis: TEM 
 
The subcellular characteristics of undifferentiated and differentiated H-
MSCs, after 3 weeks of leiomyogenic differentiation, were evaluated with 
transmission electron microscopy. The observation on H-MSCs treated 
with two well noted leiomyogenic inducible factors such as TGF-β1 and 
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PDGF-BB not showed features consistent with myofibroblast phenotype 
The induced H-MSCs showed some peripherally arranged contractile 
filaments along with profiles of rough endoplasmic reticulum; similar 
ultrastructural features was seen in the control cells (Fig.51). 
 
 
 
Fig.51: TEM analysis of leiomyogenesis. a) Smooth muscle cells with 
filaments contractile used as positive control b) Induced H-MSCs with 
arranged filaments contractile . Abbreviations: N: nuclei, Nu: nucleoli, 
rER: rough endoplasmic reticulum, FA: filaments contractile of actin 
 
 
 
 
 
 
 
a b 
rER 
N 
Nu 
 
FA 
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9. DISCUSSION 
 
Cell proliferation and vascular wall remodeling are the first responses by 
arteries to pathological environmental stress (Libby 2005, Ross 1999, 
Newby 2000). In adult life, bone marrow derived stem cells and progenitors 
are continuously mobilized into the circulating blood to target areas of 
tissue injury. These cells may pertecipate not only in physiological 
renewal, providing rapid targeted rescue for regeneration after injury by 
giving rise to fully component resident vascular cells, but also in 
phatological conditions.  
Most of the knowledge about resident vascular progenitors comes from 
animal models. Tintut et al. first demonstrated that MSCs are also present 
in the adult animal vessels. They described and isolated a subpopulation of 
vascular cells with self-renewal capacity and lineage plasticity (Tintut et al. 
2003). Vascular progenitor  cells, having stem cell markers, were found in 
the adventitia of ApoE-deficient mice and they contributed to experimental 
atherosclerosis and did not originate from the bone marrow (Hu et al., 
2004). In 2006, it has been demonstrated the presence of resident 
precursors of endothelial and smooth muscle cells in healthy arteries of 
adult mices as defined “side population” by authors, using flow cytometry 
method (Sainz 2006). More recent studies are focused on their presence and 
role in the human vascular wall. Consistent with this view, the existence of 
a capillary-rich vasculogenic zone has been identified in adult human  inner 
thoracic artery wall;  in this area, situated at the border between the media 
and adventitial layer and possibly correspond to a vascular wall stem cell 
niche, might be found not only the VW-EPC but also resident stem cells 
including MSCs and hematopoietic progenitor cells (HPCs) (Zengin et al., 
2006). This hypothesis is supported by several studies claiming to have 
found the in vivo reservoir of MSCs in post-natal tissue (da Silva Meirelles 
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et al., 2006, 2008). Several experimental observations shown that the same 
area in postnatal artery walls may contain resident MSCs with multilineage 
differentiation into different connective tissues. The presence of 
multipotent progenitors is not restrict to microvasculature; in fact,  these 
resident MSCs have been isolated from different human large blood vessels 
such as the adult thoracic aorta (Pasquinelli et al., 2007) and  pulmonary 
artery (Hoshino et al., 2008), and middle size vessels such as femoral artery 
(Pasquinelli et al, 2010), saphena vein (Covas et al., 2005) and umbilical 
veins (Covas et al., 2003). 
The upshot is that identification and characterization of the progenitors 
involved in physiological homeostasis and pathological vascular 
remodeling is an issue of great interest, one that may improve current 
knowledge of vascular diseases and may provide useful strategies that can 
be transferred to the fields of repair or regenerative medicine and tissue 
engineering as well. 
In a previous study, our group identified, in normal human adult thoracic 
aortas and femoral arteries from young and healthy heart-beating multi-
organ donors, the vasculogenic zone previously described by Zengin using 
immunohistochemical staining which make it unique in the arterial wall 
and congenial with a niche-like function (Pacilli et al., 2009, Pasquinelli et 
al., 2006, 2007c); we also isolated and described the presence of resident 
MSCs (VW-MSCs) with angiogenic ability (Pasquinelli et al., 2007 a) and 
adipogenic, osteogenic, chondrogenic and leyomiogenic potential 
(Pasquinelli et al. 2010) that present features similar to the mesenchymal 
stromal cells in bone marrow. All these evidences justify the research for 
adequate alternative sources of these cells for autologous and allogenic use. 
To furnish a direct prove of  VW-MSCs  involvement in vascular 
remodeling, repair and in stress conditions, we optimize a new useful 
approach consisting in a long-term organ culture system, up to 70 days, 
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which gives the opportunity to follow the spontaneous vascular wall 
remodeling in a three-dimensional system without the influence of 
circulating blood components. The experiment was performed on healthy 
adult human femoral artery segments. The morphological analysis of 
vascular  tissue revealed that, while the structural organization of intimal 
layers was unchanged over time, the media and adventitial tunic had the 
different behaviors. Until day 42 of culture, while muscular component 
gradually decreased, the adventitial layer shows an increase of cellularity 
due to the appearance of spindle cells. From  day  42 onwards, the smooth 
muscle cells underwent a progressive cell death, while adventitia became 
repopulated. The most interesting finding of this study was that a new 
pseudo-intimal monolayer was formed during culture in the outer layers of 
vascular wall. The immunophenotype analysis of resident cellular 
components involved in parietal remodeling process confirmed their 
undifferentiated status. We also observed a well developed plexus of 
CD34+/CD31- small vessels at the border between the media and 
adventitia layers which topographically corresponds to the CD34+/CD31- 
cell layers already observed in human inner thoracic arteries and human 
thoracic aortas; recent studies reported that this zone is highly vasculogenic 
(Zengin et al., 2006, Pasquinelli et al., 2007a). Extending our observation, 
we found that the resident vascular wall cells involved in the process of 
remodeling in the adventitial tunic had a fibroblast-like appearance with 
long cytoplasmic projections and expressed  molecules commonly found in 
MSCs such as CD44, CD90 and CD105. Again, ultrastructural 
investigation revealed a strict resemblance with MSCs. At the same time, 
the intima was lined with a similar layer composed by spindle cells, which 
showed a mature endothelial phenotype CD31
+ 
 while focally expressing 
CD34
+
. We could not exclude that this spontaneous phenomenon involve 
two distinct progenitors located in different functional areas of the wall; an 
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alternative hypothesis could invoke the role of ECM in driving functional 
differentiation close. Noteworthy was the observations of elongated 
elements expressing the stem cell surface marker c-kit. This subpopulation 
of c-kit+ cells was found in the adventitia stroma close to neoformed 
adventitial layer and in association with the vasculogenic area.  
On the basis of these observations we retain that H-MSCs could have an 
important role in the onset of vascular pathologies, i.e. atherosclerosis and 
aneurysms. 
We focused our attention on pathological cases of homografs of femoral 
arteries, furnished by operating room of Vascular Surgery of the S.Orsola-
Malpighi General Hospital of Bologna, to identify and to localize in situ, 
with immunoistochemical analysis, the adult stem cell populations that 
could be reside in the vasculogenic zone and to understand their role in the 
vascular wall remodeling. Subsequently,  we isolated this cell population 
and tested in vitro their multilineage differentiation potential through 
immunohistochemical, immunofluorescence, RT-PCR and ultrastructural 
analysis. Immunohistochemical tissue studies,  using specific antibodies 
commonly expressed by mesenchymal stem cells, showed a highly CD44 
positive cell layer and some other elongated cells weakly positive for 
CD90; these cells weremainly localized in the vasculogenic zone 
corresponding to the border line between medial and adventitial tunicas of 
the homograft wall. Besides, even pericyte and perivascular cells of the rich 
vascular plexus present in the adventitial tunica showed an high positivity 
for CD44 and a low positivity for CD90. Near the vasculogenic zone were 
also observed few CD105 and CD166 weakly positive cell.  
These observations confirmed the existence of a vasculogenic zone also in 
pathological arteries which localize at the border line between the medial 
and adventitial tunicas, containing a resident population of stem cell 
potentially able to generate, in a specific hierarchic organization, stromal  
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supporting elements (MSC). The different expression of some 
mesenchymal  markers from the healthy counterpart suggest a probably 
dissimilar grade of stemness, commitment and multipotential of the 
homograft derived MSCs which could explain the irreversible status of 
vascular damage. Hence, we  isolated a cell population from vascular wall 
homografts which shared many properties with mesenchymal stem cells 
and we named these cells Homograft derived Mesenchymal Stem Cells (H-
MSCs). From 25-30cm
2
 of each homograft sample, we obtained 1,5x10
6
 to 
3,5x10
6 
mononuclear cells using a combination of enzymatic and 
mechanical procedures and, subsequently, the cells were seeded in culture 
plate with D-MEM supplemented with 10% FBS and then cultured at 37°C 
in 5% CO2 humified atmosphere.  Cell isolation was carried out 
successfully in two cases. The remaining case was discarded due to fast 
growth of contaminant bacteria at passage 2. After 2 days from initial 
seeding, the non-adherent cells were discarded; the adherent cells shared 
many morphological properties of MSCs isolatedfrom bone marrow, such 
as: a strong adherence to plastic, a fibroblast-like spindle-shape 
morphology, a tendency to grow in colonies, and a highl proliferative 
ability (Dominici et al., 2006). An additional finding comes from results 
with alamar blue assay. The assay highlight that proliferative capacity of  
these cells increases with time,  reaching a plateau on day 10 and then 
remaining almost constant until day 21 (end of the experiment). High cell 
proliferation was also confirmed by Ki-67 positive immunofluorescence, a 
cell proliferation marker able to recognize a nuclear protein expressed in 
the G1, S, M and G2 phases of the cell cycle. The final number of resident 
mesenchymal stem cells isolated from 25 cm
2
 of each homograft segment 
was estimated around ≈ 0,5-2,0x104 cells. All these data demonstrate that 
MSC are present in failed homografts.  
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The fibroblast-like cells had the typical antigen expression pattern of 
culture-expanded MSCs; the majority was positive for a mixture of 
molecules commonly found in MSCs such as CD90, CD44, CD105, CD29, 
CD73; moreover stemness molecules such as Notch-1, Oct-4, Sca-1, Stro-1 
were also expressed. These cells also expressed NG2, a pericyte marker; 
this finding support the recent evidence that pericytes may represent the 
MSC in situ counterpart (Covas et al.,2008, Crisan et al., 2008, da Silva 
Meirelles et al., 2008, Doherty et al., 1998, Farrington-Rock et al., 2004). 
On the contrary, they were negative for the early and late hematopoietic 
markers CD34, CD133 and CD45. H-MSCs were also negative for KDR, 
CD146, CD31 and vWF which are markers of differentiated endothelium 
whilst c-Kit was not detected. The immunophenotype of isolated H-MSCs 
was: CD44
+
, CD90
+
, CD105
+
, CD29
+
, CD73
+
, Sca-1
low
, Stro-1
+
, Oct4
+
, 
Notch-1
+
, CD45
-
, CD34
-
, CD133
-
, KDR
-
, CD31
-
, vWF
-
, CD146
-
, c-Kit
-
 and 
NG2
+
. Again, ultrastructural investigation revealed a strict resemblance 
with MSCs from bone marrow. After culturing, these cells showed high 
ratio nucleus/cytoplasm with a large euchromatic nuclei and prominent 
nucleoli; a multivacuolar appearance and a high synthetic competence. i.e. 
prominence of rough endoplasmic reticulum with dilated cisternae. More 
careful observation of peripheral cytoplasm showed the presence of 
collections of clear vesicles, vacuoles and blisters giving a labyrinthine 
appearance (Pasquinelli et al., 2007 b). 
Besides flow cytometry analysis, a immunofluorescence staining confirms 
the mesenchymal status of H-MSCs as showed by intense vimentin 
positivity; the smooth muscle cell phenotype was excluded because of  the 
presence of only rare cells positive for the α-SMA and the negativity for 
other smooth muscle markers like h-Caldesmon, desmin and PDGF-rβ. The 
loss of contractile filaments by vascular cells may explain the development 
of aneurysmatic pathology.  
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Stem cells gene expression analysis by RT-PCR revelead that H-MSCs 
express transcripts associated with stem cells; some of these molecules are 
indeed involved in stem cell specific functions such as BCRP1,maintaining 
the undifferentiated state of embryonic stem cells; Notch-1, suggesting a 
major role in regulating the stemness and the undifferentiated status of H-
MSCS. To explain the low expression level of Oct4, we hypothesized that a 
subset of VW-MSCs had more ancestral characteristic Moreover, the H-
MSCs showed very low expression of KDR, VEGF receptor type 2, as well 
as CD133 an hematopoietic stem cell transcript. The expression of the 
BCRP-1 molecule is also linked to the specific ability of stem cells to 
exclude dyes such as rhodamine and Hoechst. This property that identifies 
a small subset of stem cells termed the “side population” (SP), is related to 
the expression of specific transporter proteins(Pasquinelli et al., 2010).  
We also studied the multipotency of H-MSCs; in particular we examined 
their angiogenic, adipogenic, osteogenic, chondrogenic and leiomyogenic 
abilities. VEGF preconditioned H-MSCs showed a poor ability in forming 
neovessels in a Matrigel assay. After 2 hours of culture, the H-MSCs 
rapidly aligned and formed hollow tube-like structures with thin 
cytoplasmic projections sprouting from the cell periphery. After 4 hours, 
the same cells appeared connected by thicker projections forming an 
evident capillary-like network but after only 6 hours this capacity was lost. 
This angiogenic ability was strictly depended on VEGF induction; controls 
never formed capillary structures. VEGF induction was accompanied by a 
moderate increase in  vWF cell expression; VEGF expression was 
upregolated as documented by flow cytometry and RT-PCR assay and 
confirmed by immunofluorescence staining. This low angiogenic 
commitment could be explained with the complete absence of expression 
of KDR and a lower expression of the VEGF type-I receptor, FLT-I. The 
VEGF-A through the interaction with its receptors (VEGF-R1/Flt-1, 
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VEGF-R2/KDR/Flk-1) plays a major role in driving angiogenesis in vivo; 
it promotes cell proliferation as well as migratory and sprouting activity, 
and contribute to the formation of capillary-like structures. These effects 
seem to be maintained largely by the interaction of VEGF-R2 or KDR. 
Also, the ultrastructural features confirmed the H-MSCs angiogenic failure; 
we didn‟t observe characteristics consistent with endothelial phenotype 
such as Weibel-Palade bodies. On the contrary, the VW-MSCs isolated 
from healty vascular segments are more prone to angiogenesis and 
presumably able to repair vascular defects and to supply dead cells 
(Pasquinelli et al., 2007a). H-MSCs exhibit a good propensity for 
osteogenic commitment. After 10 day of osteogenic conditioning, we noted 
morphological changes, such as the loss of cytoplasmic processes; and the 
quantity of calcium deposition increased with the time of induction. The 
von Kossa staining, performed on H-MSCs after three weeks of osteogenic 
induction, confirmed the presence of marked brownish calcium deposits 
that were spread evenly across the plate. The TEM analysis revealed that 
ossification corresponded to a stage preceding the formation of the 
trabecular bone; in fact, at the end of osteogenic assay, we observed an 
osteoid matrix enriched with multiple foci of electron dense fibrillary 
deposits which were decorated with needle-shaped hydroxyapatite crystals. 
By contrast, undifferentiated H-MSCs retained their morphology and did 
not display calcium deposition in extracellular matrix. As for adipogenesis, 
after three complete rotations of cell culture with adipogenic induction 
medium and adipogenic maintenance medium, we observed the presence of 
multiple lipid-rich vacuoles into cytoplasm which were intensely stained 
with the lipid dye Oil Red O; the lipid dropletsincreased in size and number 
with the time of induction. Ultrastructural observation of multiple and 
confluent lipid droplets in the cytoplasm, small dense mitochondria and 
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numerous endocytic vesicles, confirmed the propensity of H-MSCs for 
adipogenesis. Unconditioned cells did not display cytoplasm lipid vacuoles. 
Regarding chondrogenesis, we noted that H-MSCs cultured for three weeks 
in a medium without serum and containing transforming growth factor-β3 
under hypoxic condition, were embedded in an abundant proteoglycan-rich 
extracellular matrix intensly stained  by alcian blue. Chondrocyte-like 
lacunae were observed and markers of cartilaginous differentation such as 
human type II collagen was detected focally in extracellular matrix by 
immunohistochemistry analysis. More careful ultrastructural observation 
confirmed the presence of abundant extracellular matrix containing mature 
and immature collagen fibers and proteoglycan particles in induced cells 
exclusively. Probably the intense mesengenic differentiation ability i.e. 
adipogenic, osteogenic and chondrogenic could be  related to the pathology 
of the arterial wall. Moreover, it should be noted that “ectopic” tissues, e.g. 
cartilage, bone and fat can be seen during histopathological observation 
especially in atherosclerosis and other vascular diseases (Abedin et al., 
2004). Unlike the healthy counterpart that has a low ability to form 
calcification, H-MSCs performed this task efficiently. This could explain a 
high propensity to ossify unlike his a low predisposition (Pasquinelli et al., 
2007a).  
Also interesting were the observations from leiomyiogenic commitment. 
We had already noted that basal cells did not express contractile proteins 
thus we performed a smooth muscle induction to evaluate if  the expression 
of tipical smooth muscle proteins such as ASMA, calp2  and  H-caldesmon  
could be induced. After differentiation we observed that no smooth muscle 
proteins are present in both uninduced and induced samples, although RT-
PCR analysis showed an high expression of their transcripts. These results 
are very important because even if the H-MSCs did not acquire the smooth 
muscle phenotype, their genetic controls spountaneosly cause an 
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upregulation of contractile genes to compensate the loss of protein and to 
recover their native function. In aneurysmatic cells probably exist a post-
transcriptional regulation of smooth muscle and contractile genes which 
determine the absence of the respective proteins and the loss of vascular 
function. 
In conclusion, this study confirms the recent acquisition that the MSC 
compartment is more widely distributed than previously thought; it further 
highlights that MSCs are resident in a vasculogenic niche of healthy and 
pathological vascular walls.   
The present work demonstrates the existence of resident H-MSCs with 
morphological, phenotypic and functional mesenchymal stem cells 
properties also in a human failed homograft. H-MSCs are long-lived in 
culture, highly proliferating and multipotent for their strong ability to 
differentiate into adipocytes, osteocytes and chondrocytes. Their vascular 
plasticity suggests that these cells could participate in arterial homeostasis 
and remodeling in a normal artery but in a pathological condition these 
results suggest that H-MSCs have an important role in the pathological 
vascular remodeling wall of the atherosclerosis and aneurysms.  
The study of H-MSCs could elucidate the pathological mechanisms of 
vascular aneurysms and may be useful for the development of new 
therapeutic strategies. 
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